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1 Introduction 
1.1 Dendritic cells 
1.1.1 The role of dendritic cells in the immune system 
Host defence against microbial pathogens relies on a concerted action of both 
antigen-non-specific innate immunity and antigen-specific adaptive immunity 
(64,84,125). Key features of the innate immune system include the ability to rapidly 
recognize pathogens and/or tissue injury and the ability to signal the presence of 
danger to cells of the adaptive immune system (121). The innate immune system 
comprises phagocytic cells, natural killer (NK) cells, complement and interferons 
(IFN). Cells of the innate immune system use a variety of receptors to recognize 
patterns shared between pathogens, e.g. bacterial LPS, carbohydrates, and double-
stranded viral RNA (2,32,134). Evolutionary pressure has led to the development of 
adaptive immunity, the key features of which are the ability to rearrange genes of 
the immunoglobulin family, permitting creation of a large diversity of antigen-specific 
clones and immunological memory. However, this highly sophisticated and potent 
system needs to be instructed and regulated by antigen presenting cells (APCs). DCs 
are unique APCs because they are the only ones that are able to induce significant 
primary immune responses, thus permitting establishment of immunological memory 
(18,20,78,198). 
DCs represent a heterogeneous cell population, residing in most peripheral tissues, 
particularly at sites of interface with the environment (skin, mucosa) (17). They 
display a high phagocytic capacity. Following tissue damage, DCs process the 
captured antigens, load them onto MHC molecules and migrate to the secondary 
lymphoid organs, where they present the antigenic peptides in the context of MHC 
molecules to T cells, thereby initiating adaptive immune responses (73,205). DCs 
activate antigen-specific CD4+ T helper cells, which in turn regulate the immune 
effectors, including antigen-specific CD8+ cytotoxic T cells (CTL) and B cells, as well 
as non-antigen-specific macrophages, eosinophils and NK cells. Moreover, DCs 
induce effector cells to home to the site of infection (17). Four stages of DC 
development have been delineated: (i) bone marrow progenitors; (ii) precursor DCs 
that are patrolling through blood and lymphatics as well as lymphoid tissues, and 
that upon pathogen recognition, release large amounts of cytokines, e.g. IFN-γ; (iii) 
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tissue-residing immature DCs, which possess high endocytic and phagocytic capacity 
permitting antigen capture; and (iv) mature DCs, present within secondary lymphoid 
organs, that express high levels of costimulatory molecules permitting antigen 
presentation and T cell activation (Fig.1.1).  
 
 
Fig. 1.1: The life cycle of dendritic cells (from Banchereau (17)). Circulating precursor DCs enter 
tissues as immature DCs. They may directly encounter pathogens that induce secretion of 
cytokines (e.g. IFN-γ). Immature DCs reside at strategically important sites in the 
periphery to encounter pathogens. After antigen capture, immature DCs migrate to 
lymphoid organs where, after maturation, they display peptide-MHC complexes, which 
allows selection of rare circulating antigen-specific lymphocytes. These activated T cells 
help DCs in terminal maturation, which allows lymphocyte expansion and differentiation. 
Activated T lymphocytes migrate and reach the injured tissues. Helper T cells secrete 
cytokines, which permit activation of macrophages (MF), NK cells and eosinophils. 
Cytotoxic T cells eventually lyse the infected cells. B cells become activated after contact 
with T cells and DCs and then mature into antibody-producing plasma cells. It is believed 
that, after interaction with lymphocytes, DCs undergo apoptosis. 
 
In addition to T cell priming, DCs appear to maintain essentially survival of naive 
CD4+ T cells (33) and immune T cell memory (159). Importantly, DCs are also 
involved in the tolerization of the T cell repertoire to self-antigen. This occurs in the 
thymus (central tolerance) by deletion of developing T cells recognising self-antigens 
(33), and in lymphoid organs (peripheral tolerance) probably by the induction of 
anergy or deletion of mature T cells. 
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1.1.2 Dendritic cell activation and maturation 
Immature DCs reside in peripheral tissues at sentinel positions where they take up 
self and non-self antigens. However, they are not able to present the antigens. 
Immature DCs accumulate MHC molecules intracellularly and present only a small 
fraction at the cell surface (37,155). Three types of antigen uptake are known: 
macropinocytosis, phagocytosis and clathrin-mediated endocytosis (69,172,220,221). 
Different types of antigens are internalised via these different routes. The 
constitutive and cytoskeleton-dependent process of macropinocytosis allows rapid 
and non-specific sampling of large amounts of surrounding fluid and results in the 
formation of large intracellular vacuoles. Phagocytosis is a receptor-mediated process 
dependent on actin assembly. In general, the receptors mediating phagocytosis of 
pathogens are also engaged in clathrin-mediated endocytosis of soluble antigens. 
The latter allows uptake of macromolecules through specialized regions of the 
plasma membrane, termed coated pits (194). A large number of endocytic receptors 
are expressed on immature DCs, namely C-type lectins (93,172,210), receptors for 
the Fc portion of immunoglobulins (FcRs) (122,152), complement receptors (154), 
receptors for heat shock proteins (8,21), and scavenger receptors (148).  
A signal from pathogens, often referred to as danger signal (67), induces DCs to 
enter a developmental program, called maturation, which transforms DCs from 
sentinels into efficient APCs and T cell stimulators (17). The danger signal can be a 
bacterial or viral product as well as an inflammatory cytokine. Danger signals are 
recognized through specific pattern-recognition receptors, such as Toll-like receptors, 
FcR and cytokine receptors (125,152).  
Maturation of DCs is accompanied by fundamental morphological and functional 
changes. Antigen uptake, phagocytosis as well as macropinocytosis is down-
regulated (172). In addition, MHC molecules are redistributed from intracellular 
endocytic compartments to the cell surface (37,155). Antigen processing, peptide 
loading as well as the half-life of MHC molecules is increased (37,155). Finally, the 
surface expression of T cell co-stimulatory molecules, such as CD80, CD86 or CD40, 
also rises (Fig. 1.2).  
Simultaneously with the modifications of their antigen presentation abilities, 
maturation induces migration of DCs out of peripheral tissues (9) to the secondary 
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lymphoid organs. Modifications in the expression of chemokine receptors (e.g. CCR7) 
and adhesion molecules (e.g. ICAM-I), as well as profound changes of the 
cytoskeleton organization contribute to the migration of DCs (173). 
 
immature DC mature DC
High intracellular MHC class II (MIIC)
High endocytosis
High phagocytosis
Low CD54, CD58, CD80, CD86
Low CD40, CD25, IL-12
Actin cables
High surface MHC class II
Low endocytosis
Low phagocytosis
High CD54, CD58, CD80, CD86 
High CD40, CD25, IL-12
No actin cables
pathogens
cytokines
T cells
 
 
Fig. 1.2: Features that change during DC maturation. 
 
1.1.3 Mouse dendritic cells  
At least three distinct pathways of DC development have been identified in mice, the 
myeloid, the lymphoid and recently the plasmacytoid pathway. Evidence for a 
myeloid DC lineage derives mainly from in vitro differentiation studies, in which 
myeloid-committed precursors give rise to both granulocytes/monocytes and myeloid 
DCs under the influence of granulocyte/macrophage colony-stimulating factor (GM-
CSF) (88,176). DCs can also arise from lymphoid-committed precursors 
(5,174,199,217,222). Lymphoid and myeloid DCs differ in phenotype, localization, 
and function. Both subsets express high levels of CD11c, MHC class II, and the co-
stimulatory molecules CD86 and CD40. The former hypothesis that mouse CD8α- DCs 
were myeloid-derived and CD8α+ DCs lymphoid-derived has been challenged by 
recent findings that CD8α- and CD8α+ DCs could both be derived from either 
lymphoid- or myeloid-committed precursors (119,149). Markers such as DEC-205 and 
CD1d are expressed at higher levels on lymphoid DCs, but they can be up regulated 
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on myeloid DCs by in vitro culture (119,149,216,222) or LPS treatment. Lymphoid 
DCs are localized in the T cell–rich areas of the periarteriolar lymphatic sheaths 
(PALS) in the spleen and lymph nodes (51,109,149,199). In contrast, myeloid DCs 
are in the marginal zone of the spleen (51,109,149,199) but migrate to the PALS by 
signals such as LPS (51). The lymphoid DCs produce higher levels of interleukin (IL)-
12 (118,138,149,153) and are less phagocytic than myeloid DCs (109,149). In vitro, 
the lymphoid DCs were reported to prime allogeneic CD4 and CD8 T cells less 
efficiently than myeloid DCs (100,201). In vivo, both lymphoid and myeloid DCs 
appear to prime antigen-specific CD4+ T cells efficiently (118,150). The mouse 
counterpart for human plasmacytoid DCs shows an immature CD11clow, CD8α-, 
CD11b-, CD45RA+ phenotype and produce IFN-α. 
 
1.2 Antigen processing and presentation 
CD8+ and CD4+ T cells express clonally distributed T cell receptors (TCR) which 
recognize antigenic peptides associated with MHC class I and MHC class II 
molecules, respectively. A more or less strict compartmentalization of MHC class I 
and MHC class II biogenesis results in the loading of exogenous antigens on MHC 
class II molecules in the endocytic pathway and the selective loading of endogenous 
antigens on MHC class I molecules in the endoplasmic reticulum (ER).  
 
1.2.1 MHC class I restricted antigen presentation 
To generate CD8+ cytotoxic killer cells, APCs present antigenic peptides on MHC class 
I molecules. Most of these MHC class I ligands are derived from endogenous proteins 
(Fig. 1.3). These cytosolic proteins are degraded by the proteasome (38), further 
trimmed by cytosolic peptidases, and the derived peptides are then translocated into 
the ER via ATP-dependent TAP1/2 transporters (189). The TAP transporters belong 
to the family of ABC (ATP-Binding-Cassette) transporters. The length of the peptides 
varies between 8-14 amino acids (208). The loading of peptides onto newly 
synthesized MHC class I molecules takes place within the ER. The MHC class I-
peptide complexes are then transported through the Golgi apparatus to the cell 
surface. Several chaperones are needed for the transport of the peptides from the 
proteasome to the TAP and from the TAP to the MHC class I molecule 
(7,105,106,197). 
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Fig. 1.3: MHC class I restricted antigen presentation (from Salome Landmann (107)). 
 
1.2.2 MHC class II restricted antigen presentation 
To activate CD4 T cells the antigenic peptide has to be presented on MHC class II 
molecules on the surface of APCs. The processing of exogenous antigens for 
presentation on MHC class II molecules occurs within the endocytic pathway (Fig. 
1.4). This comprises the uptake of exogenous proteins by phagocytosis, 
macropinocytosis or clathrin-mediated endocytosis. The resulting vesicles fuse with 
lysosomes in which degradation of the proteins is mediated by cathepsins and 
proteases. 
MHC class II molecules are synthesized in the ER. Soon after synthesis three α/β 
MHC class II dimers associate with a trimer of invariant chains (Ii) (49). The 
nonamers exit the ER and pass through the Golgi apparatus to a specific endocytic 
compartment, called MHC class II compartment (MIIC), in the late endosomal 
pathway. In the MIIC the Ii is degraded by several proteolytic enzymes of the 
cathepsin family (212).  
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Fig. 1.4: MHC class II restricted antigen presentation (from Salome Landmann (107)). 
 
A central region of the Ii, termed class II-associated invariant chain peptide (CLIP), 
occupies the peptide-binding groove of class II molecules (158,186) and prevents 
peptide binding of the MHC class II molecules in the ER and during the transport to 
the MIIC compartment (204). MHC class II dimers bind antigenic peptides under the 
control of two nonpolymorphic MHC class II molecules HLA-DM/H2-M and HLA-
DO/H2-O (in human/mouse) (101). These two molecules promote catalytic removal 
of CLIP and enhance peptide binding to MHC class II molecules (35,49). Once loaded 
with peptides, MHC class II molecules are transported to the plasma membrane. 
 
1.2.3 T cell activation 
The crucial first step in adaptive immunity is the activation of naive antigen-specific T 
cells by professional antigen presenting cells (APCs). APCs display three types of 
protein molecules on their surface that contribute to the activation of T cells to 
become effector T cells: (1) MHC molecules, which present foreign antigen to the T 
cell receptor, (2) co-stimulatory molecules (CD80, CD86, CD40), which bind to 
complementary receptors (CD28, CD40L) on the T cell surface, and (3) cell-cell 
adhesion molecules (CD54, CD58), which enable a T cell to bind to the antigen-
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presenting cell for long enough to become activated. The activation of T cells by 
professional APCs leads to their proliferation and the differentiation of their progeny 
into armed effector T cells. A few of the T cells become memory T cells. The 
proliferation and differentiation depends on the production of cytokines (e.g. IL-2).  
Three types of effector T cells exist. CD8 T cells or cytotoxic T lymphocytes, which 
recognize pathogen-derived peptides bound to MHC class I molecules (mostly from 
viruses). CD4 T cells recognise peptides on MHC class II molecules. Depending on 
the cytokine secretion pattern CD4 T cells develop into subtypes of T-helper cells: 
TH1 cells or TH2 cells. 
 
1.3 Infection and Immunity 
As mentioned in Chapter 1.1.1 host defence against pathogens is based on the non-
specific or innate immune system and the specific or adaptive immune system. The 
innate immune system is also the first line of defence against a pathogen because it 
is permanent present. Components of the non-specific defence are skin, epithelial 
cells, phagocytic cells, and complement. The second line of defence is specific for a 
particular type of bacterium or virus and is thus called specific immune system. 
 
1.3.1 Innate immune system 
1.3.1.1 Pattern recognition receptors  
The innate immune system uses a variety of pattern recognition receptors (PRRs) 
that can be expressed on the cell surface, in intracellular compartments, or secreted 
into the bloodstream and tissue fluids (125). The principal function of PRRs is to 
detect a limited set of conserved molecular patterns (pathogen-associated molecular 
patterns (PAMPs)) that are unique to microbes and to signal the host the presence of 
infection. The PRRs include the acute phase proteins mannan-binding lectins, C-
reactive protein, and serum amyloid protein as secreted pattern recognition 
molecules. The macrophage mannose receptor, the macrophage scavenger receptor 
and MARCO belong to the PRRs expressed on the cell surface.  
The Toll-like receptor (TLR) family is the best-characterized class of PRRs in 
mammalian cells. TLRs detect multiple PAMPs (202), including lipopolysaccharide 
(LPS) (detected by TLR4), bacterial lipoproteins and lipoteichoic acids (detected by 
TLR2), flagellin (detected by TLR5), the unmethylated CpG DNA of bacteria and 
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viruses (detected by TLR9), double stranded RNA (detected by TLR3) and single-
stranded viral RNA (detected by TLR7) (80). TLRs 1, 2, 4, 5, 6 are expressed on the 
cell surface and are specialised to recognize mainly bacterial products. In contrast 
TLRs 3, 7, 8 and 9 are localized in intracellular compartments (80,120) and detect 
viral nucleic acids in late endosomes and lysosomes (58,113).  
All PRRs sense microbial infection and trigger a multitude of antimicrobial and 
inflammatory responses like opsonization, activation of complement, phagocytosis, 
activation of proinflammatory signalling pathways, and induction of apoptosis. 
 
1.3.1.2 Complement 
The complement system is a set of plasma proteins that act together to attack 
extracellular pathogens. Complement can be activated spontaneously by certain 
pathogens or by antibody binding to the pathogen. The pathogen becomes coated 
with complement proteins that facilitate pathogen removal by phagocytes and can 
also kill the pathogen directly (92). 
 
1.3.1.3 Phagocytes 
There are two major groups of phagocytes, macrophages and polymorphonuclear 
leukocytes (PMNs). Phagocytic cells play a key role in all phases of host defence. In 
addition to engulfing opsonized particles coated with antibodies and/or complement, 
they can recognize and ingest many pathogens directly. Indeed, the same 
complement receptors by which they engulf opsonized particles recognize various 
microbial constituents. Leukocyte integrins CD11b/CD18 (CR3) and CD11c/CD18 
(CR4), which are expressed particularly on macrophages, monocytes and PMNs, 
recognize the inactivated form of the complement component C3b that remain 
attached to the pathogen surface and stimulate phagocytosis of the pathogens. 
When pathogens cross an epithelial barrier, they are immediately recognized by 
phagocytes in the subepithelial connective tissues leading to trapping, engulfment, 
and destruction of the pathogen. In addition to phagocytosis, interaction of 
pathogens with phagocytes leads to secretion of cytokines (92). 
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1.3.1.4 Inflammatory cytokines 
One important function of the innate immune response is the recruitment of 
phagocytic cells and thereby effector molecules to the site of infection by the release 
of a number of cytokines and other inflammatory mediators. The cytokines secreted 
by phagocytes are a structurally diverse group of molecules including interleukin-1 
(IL-1), IL-6, IL-8, IL-12, and tumor necrosis factor-α (TNF-α). IL-1 activates vascular 
endothelium and lymphocytes. IL-6 induces fever and the production of acute-phase 
proteins (serum amyloid protein, C-reactive protein, fibrinogen, mannan-binding 
lectin) in the liver. IL-8 is a CXC chemokine involved in neutrophil recruitment and 
activation. IL-12 activates NK cells and induces the differentiation of CD4 T cells into 
TH1 cells. TNF-α activates vascular endothelium and increases vascular permeability, 
which leads to increased entry of IgG, complement, and cells to tissues and 
increased fluid drainage to lymph nodes.  
Cells infected with viruses produce interferons. These slow down viral replication and 
enhance the presentation of viral peptides to cytotoxic T cells as well as activating 
NK cells, which can distinguish between infected and uninfected host cells. 
 
1.3.2 Adaptive immune system 
Although the non-specific innate defences are effective, they do not protect against 
all invading pathogens. Microbes have developed several strategies to evade the 
innate immune system. Therefore a second defence system has evolved, the 
adaptive immune system, including antibodies and T cells. 
 
1.3.2.1 Antibodies 
Antibodies are protein complexes produced by B lymphocytes (B cells). There are 
several types of antibodies with different immunological functions. During infection 
IgM and IgG1-4 are most important. IgM antibodies are synthesized in the early 
phase of the immune response and are found mainly in the blood. They are 
pentameric in structure and specialised to activate complement efficiently upon 
binding antigen. IgG1 and IgG3 are called opsonizing antibodies because these two 
subtypes are the most effective in opsonizing microbes. This opsonization facilitates 
the ingestion of antigens by phagocytes. IgG also mediates the attachment of 
cytotoxic cells to infected tissue, eventually leading to death of an infected cell 
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(antibody-dependent cell-mediated cytotoxicity). This mechanism serves as a 
defence against intracellular pathogens. Both IgG and IgM neutralize microbes by 
binding to the surfaces of bacteria and viruses and prevent them from attaching to 
and invading host cells. Both types of antibodies are also able to activate 
complement and neutralize toxins (92). 
 
1.3.2.2 Cytotoxic T lymphocytes (CTLs) 
On their surface, CTLs express a protein called CD8, which is associated with the T 
cell receptor, by which they recognize pathogen-derived peptides bound to MHC 
class I molecules (mostly from viruses). CTLs play a role in killing infected host cells 
similar to that of NK cells and produce proteolytic enzymes (granzymes) that trigger 
apoptosis in the infected cells. This type of attack kills the infected cells but 
commonly not the microbes. Microbes, released from infected cells, can be taken up 
by activated macrophages, which finally kill them. Alternatively, the CTLs might also 
attack the microbes by perforin and granulysin stored within their granules. First, 
perforin forms pores into the host cell membrane. By these pores granulysin enters 
the infected cell and kills the bacteria by creating pores in their membranes. 
 
1.3.2.3 T helper cells 
After activation naive CD4 T cells differentiate into either TH1 cells or TH2 cells. IL-12 
produced by PMNs or DCs stimulates NK cells to produce IFN-γ, which in turn 
stimulates CD4 T cells to differentiate into TH1 cells. IL-4 stimulates CD4+ T cells to 
develop into TH2 cells. TH1 cells produce IFN-γ, which activates macrophages 
allowing them to destroy intracellular microorganisms more efficiently. TH1 cells can 
also stimulate B cells to produce subclasses of antibodies and activate cytotoxic T 
cells. TH2 cells activate eosinophils and stimulate B cells to produce antibodies of the 
IgG1 class by secreting IL-4 and IL-5. 
 
1.3.3 Host defence against intracellular and extracellular bacteria 
Infectious agents can grow in various host compartments divided into extracellular 
compartments like intestinal lumen, tissue and blood, and intracellular compartments 
including cytoplasma and vesicles. Extracellular bacteria are usually susceptible to 
killing by phagocytes and thus have developed means to resist engulfment like 
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capsules and toxins. Antibodies as well as the complement system also provide 
protective immunity against extracellular bacteria. Intracellular pathogens invade 
host cells in order to replicate either in the cytosol (Chlamydia ssp. and Listeria 
monocytogenes) or in vesicles (Salmonella typhimurium and Legionella
pneumophila). Virulence factors called invasins can trigger uptake of bacteria in non-
phagocytic cells. One strategy of surviving phagocytosis is to escape the phagosome 
before it fuses with lysosomes. Alternatively, some bacteria are able to prevent 
phagolysosomal fusion by preventing acidification of the vacuole. 
 
 
 
1.4 The genus Yersinia  
The genus Yersinia belongs to the family of Enterobacteriaceae. They are facultative 
anaerobe, gram-negative rods with an optimal growth at 27-30°C (45). The genus 
Yersinia includes three species that are pathogenic for rodents and humans: Y. pestis
is the causative agent of plague, Y. pseudotuberculosis, and Y. enterocolitica cause 
acute or chronic enteric disorders such as enteritis, enterocolitis, and mesenteric 
lymphadenitis, which are normally self-limited. In some cases the infection leads to 
systemic manifestations like septicaemia and immunopathological sequelae including 
reactive arthritis, uveitis, and erythema nodosum (48). While a fleabite generally 
inoculates Y. pestis, Y. pseudotuberculosis and Y. enterocolitica are food-borne 
pathogens. In spite of these differences in infection routes, all three have a common 
tropism for lymphoid tissues and a common capacity to resist non-specific immune 
response, in particular phagocytosis and killing by macrophages and PMNs. Electron 
microscopy as well as cell biology examinations revealed that Y. enterocolitica and Y. 
pseudotuberculosis are largely located extracellularly (12,55,77,188,191). 
 
1.4.1 Pathogenicity factors of Y. enterocolitica 
Yersinia possesses several virulence factors encoded either by genes of the bacterial 
chromosome (157) or by genes located on the 70-kb virulence plasmid pYV (plasmid 
Yersinia Virulence) (47,87,145,195) which enables Yersinia spp. to survive and 
multiply in the lymphoid tissues of their host. Table 1 (pages 19 and 20) gives an 
overview of the pathogenicity factors of Yersinia spp. 
 
Table 1: Overview of the most important virulence factors of enteropathogenic Yersinia 
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a) Chromosomally-encoded factors 
Factor Function Literature 
Ail Mediates adhesion to and invasion in epithelial cells as 
well as serum resistance. 
(25,129,147) 
Inv Invasin, an adhesin. Initiates by binding to β1-integrins 
transport of Yersinia across the M cells, internalisation 
in epithelial cells and secretion of IL-8. 
(6,31,60,91,95,114,144,181,184)
Myf Fibrillae possibly acts as a colonization factor and leads 
together with Yst to diarrhea. 
(90) 
SodA Super oxide dismutate (Sod), enzyme for detoxification 
of exogenous oxygen radicals produced by phagocytes. 
Mediates virulence for colonization of liver and spleen, 
but not of Peyer’s patches. 
(161) 
Yst Heat-stable enterotoxin, stimulates the activity of 
guanylate cyclase of intestinal epithelial cells and leads 
to diarrhea. 
(52,151,160) 
HPI  
(High 
Patho-
genicity 
Island) 
The HPI encodes the extracellular siderophore 
Yersiniabactin (Ybt) that enables the bacteria to 
multiply under iron-depleted conditions. Genes involved 
in Ybt synthesis, transport and regulation are clustered 
in the HPI. Ybt possibly acts immunosuppressive on T 
and B cells, macrophages and PMNs. 
(11,15,75) 
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b) Plasmid-encoded factors 
Factor Function Literature 
YopE Cytotoxin, works as GAP (GTPase activating protein) for 
Rho-family proteins, blocks phagocytosis, disrupts actin 
filaments. 
(1,23,165,215) 
YopH Phosphotyrosine phosphatase, which dephosphorylates 
proteins of focal adhesions therefore responsible for up to 
50% of the antiphagocytic activity of yersiniae towards 
neutrophiles and macrophages. Suppression of oxidative 
burst in macrophages, inhibition of T and B lymphocyte 
activation. 
(22,24,72,170,175,223) 
YopO (YpkA) Serine-threonine kinase activated by G-actin causing 
autophosphorylation of serine residues. Disruption of actin 
filaments. Interacts with RhoA and Rac1. 
(19,68,94) 
YopM Strongly acidic protein containing leucine-rich repeats 
(LRRs). It traffics to the cell’s nucleus by means of a 
vesicle-associated pathway. 
(111,112,123,193) 
YopP Cysteine protease, interacts with members of the MAPK 
kinase (MKK) super family and IKK-β thereby disrupting 
MAPK and NF-κB signalling pathways leading to inhibited 
release of proinflammatory cytokines as well as induction of 
apoptosis in macrophages. 
(30,53,54,141,142,167) 
YopT Destruction of actin stress fibres by modification of RhoA, 
which is released from the plasma membrane and 
accumulates as monomeric protein in the cytosol. 
(89,146,224) 
YadA Mediates adherence to epithelial cells and phagocytes. 
Binds to collagen, fibronectin, and laminins. It protects Y. 
enterocolitica against killing by PMNs and lysis by 
complement due to the binding of factor H by YadA. 
(40,162,163,185) 
LcrV Suppression of TNF-α and IFN-γ. Inhibits the chemotaxis of 
neutrophils. Induces the production of IL-10 in 
macrophages. 
(135,192,219) 
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1.4.2 The type III secretion system of Y. enterocolitica 
By means of its type III secretion system (TTSS) gram-negative bacteria are able to 
translocate their effector proteins directly into the cytosol of host cells (66). To date 
20 different TTSS are identified in animal and plant pathogens (46). The pYV plasmid 
encodes the Yop virulon, a system consisting of secreted proteins called Yops and 
their dedicated type III secretion apparatus called Ysc. 
Upon contact with eukaryotic target cells, Yersinia bacteria build several syringe-like 
organelles at their surface (Fig. 1.5). These organelles, called the Ysc injectisome, 
are protein pumps spanning the peptidoglycan layer and the two bacterial 
membranes topped by a stiff needle-like structure protruding outside the bacterium. 
The whole organelle comprises 27 proteins. The internal part contains 10 proteins, 
which have counterparts in the basal body of the flagellum, indicating that the two 
organelles have a common evolutionary origin. The external part of the injectisome, 
which spans the bacterial outer membrane, is a homomultimeric ring-shaped 
structure with a central pore of ≈50 Å (98). The Ysc injectisome ends with a 60–80 
nm long and 6–7 nm wide needle, whereas the length is genetically controlled (130). 
Effector Yops destined for secretion through the injectisome have no classical signal 
sequence (128). Nevertheless, a minimum of 15 residues at the NH2 terminus are 
necessary for Yop secretion (4,196). 
To become secreted some of the Yops need the help of small individual chaperones 
called Syc proteins. There are two categories of Yop proteins. Some are intracellular 
effectors, whereas the others are “translocators” which are needed to deliver the 
effectors across the eukaryotic plasma membrane into the cytosol of eukaryotic cells. 
The translocators (YopB, YopD, LcrV) form a pore of 16-23 Å in the eukaryotic cell 
membrane. 
Six effector Yops have been characterized: YopE, YopH, YopM, YopJ/P, YopO/YpkA, 
and YopT. YopH is a powerful phosphotyrosine phosphatase playing an 
antiphagocytic role by dephosphorylating several focal adhesion proteins. YopE and 
YopT contribute to antiphagocytic effects by inactivating GTPases controlling 
cytoskeleton dynamics. YopP plays an anti-inflammatory role by preventing the 
activation of transcription factor NF-κB. YopP also blocks the MKKs, inhibiting the 
activation of MAPK, which abrogates activation of CREB, a transcription factor 
involved in the immune response. YopP induces apoptosis in macrophages, either 
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directly by acting upstream of Bid or indirectly by blocking the synthesis of NF-κB–
dependent antiapoptotic factors. Less is known about the role of the phosphoserine 
kinase YopO/YpkA and YopM (see also Table1 b, page 20). 
 
 
 
Figure 1.5: Secretion of Yops by the Ysc injectisome and translocation across the target 
cell membrane. (from Cornelis 2002) When Yersinia is placed at 37°C in a rich 
environment, the Ysc injectisome is installed and a stock of Yop proteins is 
synthesized. During their intrabacterial stage, some Yops are capped with their 
specific Syc chaperone. Upon contact with a eukaryotic target cell, the adhesins YadA 
or Inv interact with integrins and the bacterium docks at the cell's surface. Then, the 
secretion channel opens and Yops are exported. YopB and YopD form a pore in the 
target cell plasma membrane (MP), and the effector Yops are translocated across this 
membrane into the eukaryotic cell cytosol (C). EM, outer membrane; P, 
peptidoglycan; IM, plasma membrane. 
 
1.4.3 Immune response to Yersinia 
Enteric Yersinia spp. are enteroinvasive pathogens, which are taken up by M cells. M 
cells are specialized epithelial cells which occur within the follicle-associated 
epithelium of the Peyer's patches (12,71). M cells expose β1-integrins at their apical 
(“lumenal”) surface, which may bind to the Yersinia invasin protein (41,182). The 
entry of enteric Yersinia by this route is an ambiguous process: on the one hand, 
Yersinia may use M cells as a structure of the mucosal immune system for invasion 
of host tissue, and most likely for subsequent dissemination. On the other hand, the 
mucosal immune system is stimulated upon entry of Yersinia at the very site where 
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efficient immune responses are usually initiated. One day after M cell invasion by Y. 
enterocolitica, small microabscesses consisting of PMNs and extracellularly located 
Yersinia can be detected in Peyer’s patch tissue (14,77).  
Yersinia has evolved efficient mechanisms mediated by the outer membrane protein 
YadA and secreted anti-host effector proteins (Yops) (for references see table 1 page 
19/20) to evade host innate defence mechanisms including phagocytosis by PMNs, 
macrophages and the complement system. In accordance with these in vivo 
observations, Yersinia manifests some resistance to phagocytosis in vitro, both by 
macrophages (63,164) and by PMN (40,170,213). After replication in Peyer’s 
patches, enteric Yersinia disseminate via the lymphatics and possibly via the blood 
stream to the mesenteric lymph nodes, spleen, liver, lungs and peripheral lymph 
nodes (12). 
The adaptive immune response plays a crucial role in the clearance of a Yersinia 
infection. It has been clearly demonstrated that Yersinia infection leads to strong T 
cell responses, including activation and proliferation of CD4 and CD8 T cells, and that 
these T cells are involved in control of Yersinia (13,16,26,29,61,62,137). In fact, mice 
deficient for T cells are unable to control the pathogen, and therefore develop 
chronic progressive and fatal infection (13). Adoptive transfer of Yersinia-specific 
CD4+ or CD8+ T cells consistently mediates resistance to a normally lethal challenge 
of Yersinia (16). As protective CD4 or CD8 T cells produce cytokines such as IFN-γ 
and IL-2, but not IL-4 or IL-10, it can be concluded that TH1 or IFN-γ producing 
cytotoxic T cells are protective in yersiniosis (14,16,26,28). TH1 cells produce 
predominantly IFN-γ, and it is established that IFN-γ can activate macrophages which 
in turn might be able to kill the pathogen. 
The role of cytokines in yersiniosis has been extensively studied in mouse strains that 
are relatively susceptible (e.g., BALB/c) or resistant (e.g., C57BL/6) to Yersinia 
infection. One reason for this differential susceptibility of mice is their different ability 
to mount TH1 responses and produce IFNγ  upon Yersinia infection (10,27). Yersinia-
resistant C57BL/6 mice can be rendered Yersinia-susceptible by neutralizing IFN-γ in 
vivo with monoclonal antibodies (10). Conversely, Yersinia-susceptible BALB/c mice 
can be rendered resistant by treatment with IFN-γ. In keeping with these results, it 
was found that administration of neutralizing anti-IL-4 antibodies also rendered 
BALB/c mice resistant to Yersinia infection (10). From these data it can be concluded 
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that IFN-γ is a central protective cytokine in Yersinia infection. In addition 
experiments with cytokine- or cytokine receptor-deficient mice clearly demonstrated 
that the cytokines TNF-α, IL-12, IL-18 and IFN-γ are all essential for control of 
Yersinia infection (26,28,29,81).  
In contrast to T cell responses, protective antibodies recognize the outer membrane 
protein YadA of Y. enterocolitica (214). In Y. pestis infections, antibodies against 
LcrV, F1 antigen and YopD have been demonstrated to be protective. Together, 
these data suggest that different antigens are possibly involved in protective cellular 
and humoral immune responses. 
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1.5 Objectives and goals 
 
By means of its plasmid-encoded pathogenicity factors including the type three 
secretion system (TTSS) and YadA Y. enterocolitica is able to evade the innate 
immune system like phagocytosis by PMNs and macrophages and lysis by 
complement. Therefore the production of cytokines like TNF-α, IL-12, IL-18 and  
IFN-γ as well as the activation of CD4 T cells and macrophages are essential to 
control Yersinia infection. Herein, we addressed the question whether and how Y. 
enterocolitica also evade adaptive immunity. As DCs build a link between innate and 
adaptive immune responses and are able to prime naive CD4 T cells these cells could 
play an important role to overcome Yersinia infection. Therefore we investigated 
whether and how Y. enterocolitica affects the immunogenic properties of DCs. To 
accomplish this, DCs were infected with Y. enterocolitica and isogenic mutant strains 
deficient for plasmid-encoded virulence factors and analysed for cell viability, 
expression of co-stimulatory molecules, secretion of cytokines and antigen uptake 
and processing by DCs. Finally, we tested if Y. enterocolitica infection alters the 
ability of DCs to activate CD4 T cells. 
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2 Material and Methods 
2.1 Mice 
BALB/c mice were purchased from Harlan Winkelmann (Borchen, Germany). 
DO11.10 (86), C57BL/6x129Sv and TLR2-/-xTLR4-/- mice (110) , provided by C. 
Kirschning, were maintained under specific pathogen-free conditions in our breeding 
facility. The experiments were performed using 6 to 10-week-old female mice.  
 
2.2 Bacterial strains and growth conditions 
The Y. enterocolitica strains used in this study are listed in table 2.1.  
 
Table 2.1: Yersinia enterocolitica mutant strains used in this study 
Designation Description References 
pYV+  Serotype O:8, Y.enterocolitica WA-314; clinical isolate; 
contains virulence plasmid pYV; Nalr 
(79) 
pYV- Serotype O:8, virulence plasmid cured derivative of 
Y.enterocolitica WA-314; Nalr 
(79) 
pYV+∆yopE pYV- harbouring pYV yopE ∆17-203; Nalr, Kanar (97) 
pYV+∆yopH pYV- harbouring pYV yopH ∆17-203; Nalr, Kanar (97) 
pYV+∆yopM pYV- harbouring pYV yopM ∆17-203; Nalr, Kanar (97) 
pYV+∆yopP yopP-negative mutant, derivative of Y.enterocolitica 
WA-314, insertional inactivation of yopP; Nalr, Cmr 
(167) 
pYV+∆yopT yopT-negative mutant, derivative of Y.enterocolitica 
WA-314, insertional inactivation of yopT; Nalr, Cmr 
(167) 
pTTSS  
 
pYV- harbouring pTTSS encoding for Type III secretion 
system and YadA; Nalr, Specr 
(167) 
pTTSSyopE+ pTTSS harbouring pBM-yopE Nalr, Cmr, Specr Provided by E. Bohn 
pTTSSyopH+ pTTSS harbouring pBME53-yopH; Secretion of 
YopE53YopH fusion protein; Nalr, Cmr, Specr 
Provided by E. Bohn 
pTTSSyopM+ pTTSS harbouring pBME53-yopM; Secretion of 
YopE53YopM fusion protein; Nalr, Cmr, Specr 
Provided by E. Bohn 
pTTSSyopP+ 
 
pTTSS harbouring pBME53-yopP; Secretion of 
YopE53YopP fusion protein; Nalr, Cmr, Specr 
Provided by E. Bohn 
pTTSSyopT+ pTTSS harbouring pBME53-yopT; Secretion of 
YopE53YopT fusion protein; Nalr, Cmr, Specr 
Provided by E. Bohn 
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All strains of Y. enterocolitica were grown overnight in Luria-Bertani (LB) broth at 
27°C supplemented with the appropriate antibiotics (see Tab. 1). A 1:20 dilution of 
the overnight Yersinia culture was incubated for additional 1.5 h at 37°C. The 
bacteria were washed once with PBS (Invitrogen, Karlsruhe, Germany) and the 
optical density at 600 nm was determined. 
 
2.3 Cell cultures and infection 
Bone marrow-derived DCs and T cells were grown in RPMI 1640 (Biochrom) medium 
supplemented with 10% FCS (Sigma, Taufkirchen, Germany), 2 mM glutamine 
(Invitrogen, Karlsruhe, Germany), 100 U/ml penicillin (Invitrogen, Karlsruhe, 
Germany), 100 µg/ml streptomycin (Invitrogen, Karlsruhe, Germany), 50 µM                   
β-mercaptoethanol (Sigma, Taufkirchen, Germany), 1% (v/v) non-essential amino 
acids (Biochrom, Berlin, Germany) and 1 mM sodium pyruvate (Biochrom, Berlin, 
Germany). DCs were prepared according to the protocol of Lutz et al. (115). 2 x 106 
bone marrow cells, flushed from the femurs and tibias of mice, were seeded in 100 
mm dishes with 10 ml of medium containing 200 U/ml GM-CSF (produced by mouse 
myeloma strain P3X63). After 3 days, 10 ml of fresh medium containing 200 U/ml 
GM-CSF were added to the cultures. After 6 and 8 days, half of the culture 
supernatant was collected, centrifuged, and the cell pellet was resuspended in 10 ml 
fresh medium containing GM-CSF and given back to the original plate. At day 8 the 
slightly attached cells, 65-75 % are CD11c+, were used for the experiments 
described herein. 
For infection DCs were seeded in 48-, 24-, 12-, or 6-well plates (see particular 
experiment; non tissue culture treated plates, BD Falcon, Germany) in medium 
without antibiotics and infected with different strains of Y. enterocolitica at a 
multiplicity of infection (MOI) of 10 or stimulated with 1 µg/ml LPS (from S. 
typhimurium, Sigma, Taufkirchen, Germany). The bacteria were sedimented onto the 
cells at 400 x g for 5 min. After 1 h of infection gentamicin (0.1 mg/ml; Sigma, 
Taufkirchen) was added to kill extracellular bacteria.  
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2.4 Purification of DO11.10 CD4+ T cells 
CD4+-transgenic T cells were isolated from the spleens of 8-week-old Ova-TCR-
transgenic DO11.10 (H-2d) mice. CD4+ T cells were purified by preparing a single cell 
suspension, followed by lysis of red blood cells (80 mM NH4Cl, 5 mM KHCO3, 5 mM 
Na2EDTA). Using the CD4+ negative T cell isolation kit and the magnetic-activated 
cell sorter system (Miltenyi Biotech, Bergisch Gladbach, Germany) MHC class II+, 
B220+ and CD8+ cells were depleted. The resulting T cell preparations, containing 
97-99 % CD4+ T cells, were used without further purification.  
 
2.5 T cell proliferation assay 
DCs were infected with the indicated strains of Y  enterocolitica (1 x 10. 6 DCs in     
24-well plate). At 1 h post infection 0.1 mg gentamicin/ml and 0.1 mg OVA/ml 
(Sigma, Taufkirchen, Germany) were added and the cells were incubated at 37°C for 
another 2 h. Freshly isolated DO11.10 T cells were labelled with CFSE (5-(6)-
carboxyfluorescein diacetate N- succinimidyl ester; Molecular Probes/Invitrogen, 
Karlsruhe, Germany) as previously described (108,117) with minor modifications. 1-2 
x 107 T cells/ml were washed twice with ice-cold PBS and incubated with CFSE (5 
µM) in PBS for 3 min at 37°C. The cells were then washed twice with ice-cold heat-
inactivated FCS, resuspended in cell culture medium and used for the experiments. 
CFSE-labelled T cells (4 x 105) were co-incubated with the Ova-loaded DCs (105) in 
48-well plates. After 4 days of co-incubation, the proliferation rate was analysed by 
flow cytometry with excitation at 488 nm and the FL 1 detection channel. 
 
2.6 Assessment of apoptosis 
2.6.1 Assessment of the mitochondrial transmembrane potential 
DCs (4 x 105 in 24-well plate) were infected with different Yersinia strains as 
described above. The mitochondrial transmembrane potential (∆Ψm) was analysed 
using the ∆Ψm-specific stain TMRE (Molecular Probes/Invitrogen, Karlsruhe, 
Germany). TMRE (40 nM) was added at 3.75 h post infection and cells were 
incubated for further 15 min at 37°C. Thereafter, the cells were additionally stained 
with propidium iodide (PI,       40 ng/ml) and analysed by flow cytometry using FL-2 
channel for TMRE and FL-3 channel for PI. 
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2.6.2 Assessment of DNA fragmentation 
Nicoletti assay: 24 h after infection cells were transferred into FACS tubes (BD 
Falcon, Germany) and centrifuged at 400 g for 5 min. The pellet was resuspended in 
400 µl of Nicoletti reagent (50 µg/ml PI, 0.1% tri-sodium-citrate-2-hydrate, 0.1% 
Triton X-100, dissolved in H2O), incubated on ice for 10 min and analysed by flow 
cytometry in channel FL-3. 
 
2.7 Flow cytometry analyses of adhesion molecules 
To examine the regulation of adhesion and co-stimulatory molecules of Yersinia-
infected DCs, 5 x 106 cells (in 6-well plates) were infected as described above. At 3 h 
post infection the cells were stained with FITC-conjugated α-I-A/I-E (2G9), α-CD80 
(16-10A1), α-CD86 (GL1) or α-CD54 (3E2; all from BD PharMingen, Heidelberg, 
Germany) and propidium iodide (PI; Calbiochem, La Jolla, CA). Samples were 
analysed on a FACSCalibur flow cytometer (BD Immunocytometry Systems, 
Germany) gating on the propidium iodide negative cells. Data were analysed with 
WINMDI version 2.3 software (J. Trotter, Scripps Institute, La Jolla, CA). 
 
2.8 Determination of cytokine production by ELISA 
To study the effect of different Y. enterocolitica strains on the cytokine release of 
mouse DCs, cells (1 x 106 in 24-well plates) were infected as described above and 
the supernatants were collected after 6 h for KC ELISA (Duo Set, R&D Systems, 
Wiesbaden, Germany) and after 24 h for IL-10, IL-12 (p70) and TNF-α ELISA 
(OptEIA ELISA Set; BD PharMingen, Germany). Cytokine levels were measured 
according to the manufacturer’s instructions. 
 
2.9 Western blot analyses 
2.9.1 Iκ-Bα and Iκ-Bβ 
DCs (1 x 106 in 24-well plates) were infected as described above and at various time 
points post infection the cells were washed twice with PBS and resuspended in     
200 µl of SDS sample buffer (100 mM Tris-HCl pH 6,8, 200 mM 1,4-Dithio-DL-treitol, 
4% SDS, 20% glycerol). Extracts were transferred into reaction tubes (Eppendorf, 
Hamburg, Germany) and boiled for 5 min. Samples (7 µl) were separated by SDS-
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PAGE on a 12.5% polyacrylamide gel and electrophoretically transferred to a 
nitrocellulose membrane (Schleicher & Schüll, München, Germany). Non-specific 
binding was blocked with washing buffer (10 mM Tris-HCl, 150 mM NaCl, 0.2 % 
Tween) containing 5% skim milk for 90 min at room temperature. The membrane 
was incubated overnight at 4°C with either Iκ-Bα (1:3000; sc-371) or Iκ-Bβ (1:3000; 
sc-946; Santa Cruz, Heidelberg, Germany) polyclonal antibody. After three 5 min 
washes the membrane was incubated with horseradish peroxidase-conjugated rabbit 
anti-mouse immunoglobulin (1:1000; DAKO, Hamburg, Germany) for 1 h at room 
temperature. After further washing the bands were visualized with an enhanced 
chemiluminescence detection system (ECL; Amersham Biosciences Europe GmbH, 
Freiburg, Germany). 
2.9.2 Cathepsin S 
Lysates of endocytic organelles were prepared as described in active-site-directed 
labelling (2.12) and stored in liquid nitrogen. After thawing cell lysates were treated 
1 min in an ultrasonic bath and 2 µg of protein were resolved by 12.5% SDS-PAGE, 
transferred to PVDF membrane (Millipore, Bedford, MA, USA) and blocked with 
washing buffer containing 10% Rotiblock (Roth, Karlsruhe, Germany) over night. The 
membrane was probed 1h with a 1:7500 dilution of anti-cathepsin S polyclonal 
antiserum (kindly provided by E. Weber, University of Halle, Germany) at room 
temperature, followed by washing steps three times 1 min and three times 10 min. 
Afterwards the membrane was incubated 1h at room temperature with a 1:10.000 
dilution of secondary anti-rabbit IgG antibody coupled with peroxidase (Southern 
Biotech, Birmingham, AL, USA). An Amersham detection Kit (Amersham Pharmacia, 
Freiburg, Germany) was used to visualize the proteins. 
The western blot experiments for cathepsins were performed in cooperation with M. 
Reich, Medicine II, University of Tübingen. 
 
2.10 Electrophoretic mobility shift assay (EMSA) 
DCs (5 x 106 in 6-well plates) were infected as described above. After various 
intervals nuclear extracts were prepared as previously described (180). Aliquots of 
the supernatant containing nuclear proteins were stored at –80°C. Protein 
concentrations were determined using the Bradford assay. Oligonucleotide probes 
were labelled with [γ32P]ATP (Amersham Biosciences, Freiburg, Germany) using T4-
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Polynucleotidkinase (New England Biolabs, Frankfurt, Germany) and purified on a 
NucTrap probe purification column (Stratagene, Amsterdam, Netherlands). The 
following oligonucleotides were used (Santa Cruz, Heidelberg, Germany): 
NF-κB wild type (NF-κBc; 5’-ATGTGAGGGGACTTTCCCAGGC-3’), NF-κB mutant     
(NF-κBm; 5’-ATGTGAGGcGACTTTCCCAGGC-3’;). Nuclear extracts (3-6 µg) were 
incubated with 30 000 cpm of the 32P-labeled oligonucleotide probe for 45 min on ice 
in a buffer containing 5% glycerol, 80 mM NaCl, 1 mM DTT, 1 mM EDTA pH 8.0,    
10 mM Tris-HCl pH 7.2 and 1 µg dIDC. Antibodies against p50 (sc-1190X) and p65 
(sc-372X; Santa Cruz) were included in the binding reaction for supershift analyses. 
Samples were resolved on a 5% non-denaturating polyacrylamide gel using          
0.5 x TBE (25 mM Tris-HCl, 25 mM boric acid, 0.5 mM EDTA) as running buffer. Gels 
were transferred to Whatman 3M paper (Schleicher & Schüll, München, Germany) 
and dried under vacuum. Protein binding was assessed by autoradiography. 
 
2.11 Measurement of Ag uptake (FACS & Fluororeader) 
DCs (5 x 105 in 48-well plates or 3 x 106 in 12-well plates) were incubated with Ova-
FITC (1 mg/ml or 300µg/ml), transferrin-FITC (Tf, 1 mg/ml) or Lucifer Yellow (LY, 2 
mg/ml; all from Molecular Probes/Invitrogen, Karlsruhe, Germany) directly or after 
infection with Y. enterocolitica for 30 min at 37°C. Cells were washed three times in 
ice cold PBS/2% FCS. For flow cytometry analyses (FACS Calibur, BD Biosciences, 
Heidelberg, Germany) DCs were incubated with APC-anti-CD11c antibody (HL3, BD 
Biosciences). Ova-FITC, Tf-FITC, or LY uptake was quantified as mean fluorescence 
intensity (MFI) of CD11c+ cells. As the excitation of FITC is dependent on pH 
(considerable fluctuations between pH 5-7,5), we used lysates of DCs of pH 9 to 
analyse the total fluorescence of FITC. DCs were treated with lysis buffer (50 mM 
Tris-HCl, 150 mM NaCl, 0,5% NP-40 and 5 mM EDTA, pH 9) for 30 min on ice and 
centrifuged at 13000 x g for 30 min. The amount of protein was determined using 
the BCA Protein Assay (Perbio, Bonn, Germany) according to the manufacturer’s 
instructions. The fluorescence of 50 µg protein of each sample was analysed by a 
Fluororeader (FLUOstar OPTIMA, BMG LABTECH; Gain 1750, excitation filter 485 nm, 
emission filter 520 nm). Non-specific FITC signal was assessed by incubating cells in 
Ova-, Tf-FITC or LY at 0°C. In some conditions, cells were pre-treated with 10 µM 
cytochalasin D (Sigma-Aldrich, München, Germany), 5 µg/ml mannan (from 
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Saccharomyces cerevisiae; Sigma-Aldrich) or MAPK inhibitors SP600125 (20 µM; 
inhibiting JNK), PD98059 (50µM; inhibiting MEK1/2) and SB202190 (2µM; inhibiting 
p38; all from Merck Biosciences GmbH, Bad Soden, Germany) for 15, 10 or 30 min at 
37°C, respectively. For inhibition of Rho GTPases (Rho A, Rac1 and Cdc42) cells were 
pre-incubated with TcdB10463 (20 ng/ml; kindly provided by I. Just, Hannover, 
Germany) for 2h.  
The experiments performed with the fluororeader were done together with R. 
Rösemann, Institute for Medical Microbiology and Hygiene, University of Tübingen. 
 
2.12 Active-site-directed labelling 
DCs (5 x 106 in 6-well plates) were infected as described above. 1h post infection 
gentamicin was added and the cells were used either directly or after additional 2h at 
37°C for further purification. 10 wells were pooled for 1 sample and washed twice 
with ice cold PBS and one time with fractionation buffer (0.25 M sucrose, 10 mM 
Tris-HCl pH 6.8). Cells were homogenised for subsequent fractionation and 
centrifuged at 3000 rpm for 10 min. The supernatant was then centrifuged at   
50.000 rpm for 5 min using an ultracentrifuge. The resulting supernatant was again 
centrifuged at 100.000 rpm for 12 min to obtain a highly purified cytosolic fraction 
and a pellet containing lysosomes and endosomes. These intact endocytic organelles 
were then lysed in NP-40 lysis buffer, pH 5 (50 mM sodium acetate, 5 mM MgCl2, 
0.5% NP-40) and analysed for protein concentration using the Bio-Rad Bradford 
reagent (Bio Rad Laboratories GmbH, München, Germany). 2-5 µg/ml total endocytic 
protein were subjected to active-site-directed labelling of cysteine proteases by 
incubation with reaction buffer (50 mM citrate/phosphate pH 5.0, 1 mM EDTA,       
50 mM DTT) in the presence of 10 µM biotinylated DCSG-0N for 30 min at room 
temperature. For selective inhibition of proteases, appropriate inhibitors were added 
30 min prior to labelling. Reactions were determined by addition of SDS reducing 
sample buffer and immediate boiling. Samples were resolved by SDS-PAGE and 
transferred to PVDF. After blocking with PBS/10% skim milk, the membrane was 
probed with a 1:1000 dilution of streptavidin-horseradish peroxidase (Amersham 
Biosciences Europe GmbH, Freiburg, Germany) in PBS/0,2% Tween 20 for 60 min 
followed by five washes with PBS/0,2% Tween 20. ECL (Amersham Biosciences, 
Freiburg, Germany) was used for visualisation.  
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The active-site directed labelling experiments were performed in cooperation with M. 
Reich, Medicine II, University of Tübingen. 
 
2.13 Statistics 
The significance of the differences among different groups was determined by the 
unpaired two-tailed Student’s t test. P values < 0.05 were considered statistically 
significant.  
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3 Results 
3.1 T cell activation after infection of DCs with Y. 
enterocolitica  
T cell responses are required for elimination of Y. enterocolitica from infected tissues 
(13,16). Therefore, T cell proliferation assays were performed to analyse whether 
Yersinia infection alters the capacity of DCs to activate T cells. For this purpose DCs 
were infected with Y. enterocolitica wild type or mutant strains for one hour, then 
ovalbumin protein (Ova), used as antigen, was added to the DCs. Two hours later 
the Ova pulsed DCs were washed and co-cultured with Ova-specific CFSE-labelled 
CD4+ T cells from DO11.10 mice. T cell proliferation was analysed by flow cytometry.  
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Fig. 3.1: T cell proliferation after co-culture of DCs infected with Y. enterocolitica 
DCs were incubated with the indicated strains of Y. enterocolitica (1h, MOI 10), then 
pulsed with Ova for 2 h and co-cultured with CFSE labelled CD4+ T cells from Ova TCR 
transgenic DO11.10 mice. 4 days later T cell proliferation was analysed by flow cytometry. 
Results are representative of seven experiments. 
 
DCs incubated without Ova and further co-cultured with Ova-specific CD4+ T cells 
were used as a negative control. This condition did not lead to any T cell proliferation 
as indicated in Fig. 3.1 by one peak representing CD4+ T cell with the same amount 
of CFSE. Uninfected DCs pulsed with Ova and incubated with Ova-specific CD4+ T 
cells were used as a positive control leading to a high proliferation rate demonstrated 
by series of peaks representing T cells with declining amounts of CFSE. Infection of 
DCs with wild type Yersinia (pYV+) harbouring the virulence plasmid pYV completely 
abolished the capacity of DCs to activate T cells (Fig 3.1). In contrast, T cell 
proliferation was observed when DCs were infected with heat-killed wild type Yersinia 
(hk pYV+) or with viable plasmid-cured Y. enterocolitica (pYV-), but to a lesser extend 
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than with the positive control. These results indicate that viable Y. enterocolitica may 
affect DCs in a way which inhibits the ability of DCs to prime CD4 T cells and that 
factors encoded by the virulence plasmid are essential for this effect. 
The virulence plasmid encodes membrane proteins and effector proteins the latter of 
which are directly translocated via the TTSS into the cytosol of host cells. Our 
hypothesis was that translocated effector proteins (Yops) might affect intracellular 
functions of DCs required for their immunostimulatory capacity. To find out which of 
the Yersinia outer proteins (Yops) is responsible for the inhibited T cell proliferation, 
DCs were infected either with Yersinia mutant strains deficient for one single Yop 
(Fig. 3.2) or mutant strains secreting one single Yop only (Fig. 3.3). 
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Fig. 3.2: T cell proliferation after co-culture of DCs infected with Yersinia mutant strains 
deficient for single Yops 
DCs were incubated with the indicated mutant strains of Y  enterocolitica, then pulsed 
with Ova for 2 h and co-cultured with CFSE labelled CD4
.
+ T cells from Ova TCR transgenic 
DO11.10 mice. 4 days later T cell proliferation was analysed by flow cytometry. 
 
DCs infected with Yersinia mutant strains deficient for YopE, YopH, YopM or YopT 
completely abolished the capacity of DCs to activate T cells, similar to DCs infected 
with the wild type strain (pYV+) (Fig. 3.2). In contrast, DCs infected with the Yersinia 
mutant strain deficient for YopP led to proliferation of Ova-specific CD4+ T cells. This 
proliferation rate was comparable to that of T cells co-cultured with DCs infected 
with the plasmid-cured (pYV-) mutant strain (Fig. 3.1). From these results one can 
conclude that mainly YopP is responsible for the abolished T cell proliferation 
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triggered by DCs infected with wild type Yersinia. DCs infected with mutants 
secreting single Yops only, showed similar capability to activate CD4+ T cells as the 
control mutant pTTSS (Fig. 3.3). Thus, infection of DCs with pTTSSyopP did not lead 
to decreased T cell proliferation indicating that YopP alone is not able to reduce T 
cell activation capacity of DCs and that the interplay with other Yops is essential. 
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Fig. 3.3: T cell proliferation after co-culture of DCs infected with Yersinia mutant strains 
translocating single Yops 
DCs were incubated with the indicated mutant strains of Y  enterocolitica, then pulsed 
with Ova for 2 h and co-cultured with CFSE labelled CD4
.
+ T cells from Ova TCR transgenic 
DO11.10 mice. 4 days later T cell proliferation was analysed by flow cytometry. 
 
The proliferation rates of infected DCs slightly varied between experiments. This 
could be due to the inaccurate determination of the amount of bacteria given to the 
DCs. To confirm this possibility DCs were incubated with different multiplicities of 
infection (MOI) and T cell proliferation was analysed thereafter. Figure 3.4 
demonstrates, that all Yersinia mutant strains including plasmid-cured (pYV-) and 
wild type heat-killed Yersinia were able to inhibit T cell proliferation at high rates of 
MOI, suggesting that MOIs of 50 cause non-specific toxicity to DCs. In contrast to 
this, DCs infected with all mutant strains at a MOI of 0,5 or 1 showed no difference 
in promoting T cell proliferation suggesting that the amount of Yersinia effector 
proteins translocated into DCs by Y. enterocolitica is too low to accomplish 
modulation of DCs. A minimum of 2 to 5 bacteria to DCs is necessary to observe 
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differences in T cell activation capacity of DCs infected with different Yersinia mutant 
strains. 
Together, these data suggest that gene products encoded by the virulence plasmid 
affect DC functions required to promote T cell proliferation. Several factors like 
induction of apoptosis, inhibition of maturation, antigen uptake, and processing may 
affect DCs to prevent T cell proliferation. Therefore, the effect of Y. enterocolitica 
wild type and mutant strains on the function of DCs was analysed in more detail. 
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Fig. 3.4: T cell proliferation after co-culture of DCs infected with different multiplicities 
of infection (MOI) of Yersinia mutant strains  
DCs were incubated with the indicated mutant strains of Y. enterocolitica, then pulsed 
with Ova for 2 h and co-cultured with CFSE labelled CD4+ T cells from Ova TCR transgenic 
DO11.10 mice. 4 days later T cell proliferation was analysed by flow cytometry. 
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3.2 Y. enterocolitica induces apoptosis in DCs 
Previous studies demonstrated that Y. enterocolitica induces apoptosis in mouse 
macrophages (53,169) but not in human DCs (178). To assess whether Y. 
enterocolitica induces death of mouse DCs, and whether this event might be 
responsible for the reduced ability of DCs to stimulate T cells, different assays 
analysing features of apoptosis were performed with DCs infected with Y. 
enterocolitica (Fig. 3.5). The loss of mitochondrial membrane potential (∆Ψ) is a 
hallmark of apoptosis. The mitochondrial permeability transition is an important step 
in the induction of cellular apoptosis. During this process, the electrochemical 
gradient (referred to as ∆Ψ) across the mitochondrial membrane collapses. The 
mitochondrial membrane potential (∆Ψ) was determined by flow cytometry using the 
mitochondrion selective dye tetramethylrhodamine ethyl ester (TMRE) with an 
excitation wavelength of 568 nm. In healthy cells TMRE is accumulated by the 
mitochondria in proportion to the ∆Ψ. In DCs, accumulation of TMRE in the 
mitochondria results in high fluorescence intensity. In apoptotic cells, where the 
mitochondrial membrane potential is compromised, TMRE is not accumulated in the 
mitochondria and therefore the fluorescence intensity of TMRE is low. 
To analyse the integrity of cellular membranes, cells were additionally treated with 
propidium iodide (PI), which is taken up by the cells when the membrane is 
disrupted. Staurosporine, an inductor of apoptosis, was used a positive control. 
Figure 3.5A demonstrates, that four hours after infection with Y. enterocolitica, most 
DCs were TMRE negative (11.6%) and propidium iodide positive (61.7%) while most 
non infected viable DCs (medium control) were PI negative and TMRE positive 
(73.2%). These data indicate the loss of mitochondrial membrane potential and 
damage of the cellular membrane in DCs infected with Y. enterocolitica strain (pYV+). 
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Fig. 3.5: Death of DCs after infection with Y. enterocolitica 
DCs were left untreated (medium) or incubated with staurosporine or wild type Y. 
enterocolitica (pYV+; MOI 10). 4 h post infection DCs were stained with (A) TMRE and 
propidium iodide (PI). To assess DNA fragmentation DCs were stained 24 h post infection 
with PI after cell lysis (B). 
 
To assess DNA content of the nuclei, DCs were lysed and resuspended with Nicoletti 
reagent including a high concentration of PI. After this treatment PI incorporates in 
the DNA. The more DNA fragmentation (a hallmark of apoptosis) is obvious in the 
cells the lesser the PI signal is. DNA fragmentation, a late event in the apoptotic 
process, was obvious 24 h after infection with the Y. enterocolitica wild type strain 
(pYV+) as indicated by a decreased PI staining in Nicoletti assays (Fig. 3.5B). 
Therefore, it can be concluded that wild type Y. enterocolitica (pYV+) induced death 
of mouse DCs. To confirm this data electron microscopy analyses were performed 
with DCs incubated with staurosporine or infected with Y. enterocolitica (pYV+). 
Figure 3.6 shows that DCs treated with staurosporine exhibited typical features of 
apoptosis like condensation of chromatin and nuclear segmentation. In contrast, 
predominantly large cells with vacuolized cytoplasm were observed in DCs infected 
with Y. enterocolitica, whereas chromatin condensation was not prominent. These 
data suggest that Y. enterocolitica-mediated cell death of mouse DCs exhibits 
features of both, apoptosis and necrosis. 
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Fig. 3.6: Death of DCs infected with Y. enterocolitica  
Electron microscopic analyses of DCs incubated with medium demonstrated normal 
morphology of cells, while treatment with staurosporine or infection with wild type Y. 
enterocolitica (MOI 10, 4 h) induced numerous apoptotic bodies containing cytoplasmic 
and chromatin remnants. 
 
In contrast to infection with wild type Y. enterocolitica (pYV+), apoptosis was not 
induced by plasmid-cured (pYV-) or by heat-killed wild type Yersinia (hk pYV+; Fig. 
3.7), indicating a role of effectors encoded by the virulence plasmid. Therefore, DCs 
infected with mutants deficient for a single Yop as well as mutants secreting single 
Yops only were analysed for early and late events of apoptosis (Fig. 3.8).  
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Fig. 3.7: Death of DCs after infection with Y. enterocolitica 
DCs were left untreated or incubated with staurosporine or different strains of Y. 
enterocolitica (pYV+, pYV-, heat-killed (hk) pYV+, pYV+∆yopP; MOI 10). 4 h post infection 
DCs were stained with TMRE and PI (left panel), and 24 h post infection cells were lysed 
and nuclei were stained with PI only (right panel). Results are representative of three 
experiments. 
 
The YopP-deficient mutant strain (pYV+∆yopP) was not able to induce apoptosis in 
mouse DCs in contrast to all other mutants deficient for a single Yop (Fig. 3.8). 
According to this only the pTTSSyopP mutant strain was able to induce apoptosis in 
DCs (Fig. 3.8). Therefore, YopP appears to be the most important factor involved in 
cell death of DCs caused by Yersinia. 
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Fig. 3.8: YopP of Y. enterocolitica induces death in DCs 
DCs were incubated with staurosporine or infected with the wild type or different mutant 
strains of Y  enterocolitica either deficient for a single Yop (A) (pYV. +, pYV+∆yopE, 
pYV+∆yopH, pYV+∆yopM, pYV+∆yopP, pYV+∆yopT) or translocating a single Yop (B) 
(pTTSSyopE, pTTSSyopH, pTTSSyopM, pTTSSyopP, pTTSSyopT). (A) 4 h post infection 
DCs were stained with TMRE and PI and analysed by flow cytometry. Numbers indicate 
percentages of cells in each quadrant. (B) 24 h post infection DCs were lysed and nuclei 
were stained with PI (Nicoletti) and analysed by flow cytometry. Numbers indicate 
percentages of fragmented nuclei. Results are representative of three experiments.  
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3.3 Surface molecule expression by DCs after infection with 
Y. enterocolitica  
Maturation of DCs is accompanied by changes in the expression of surface 
molecules. To examine whether Y. enterocolitica modulates maturation of DCs the 
expression of molecules, which contribute to immunological synapse formation, 
including the expression of MHC class II, co-stimulatory, and adhesion molecules 
(CD80, CD86, ICAM-1), was analysed by flow cytometry.  
Three hours after incubation with either LPS, plasmid-cured (pYV-), or YopP-deficient 
mutant strain (pYV+∆yopP) of Y. enterocolitica, expression of MHC class II was 
markedly increased compared to untreated DCs (Fig. 3.9). Increased MHC class II 
expression in DCs was also observed after infection with Y. enterocolitica wild type 
(pYV+) strain, although expression was less compared to DCs infected with Yersinia
pYV
 
- and pYV+∆yopP. The co-stimulatory molecules CD86 and CD80 as well as the 
adhesion molecule ICAM-1 (CD54) were strongly expressed on DCs after incubation 
with LPS or infection with plasmid-cured (pYV-) or the YopP-deficient mutant strain 
(pYV+∆yopP) of Y. enterocolitica, whereas no increased expression was observed 
after infection with wild type Y. enterocolitica (pYV+; Fig. 3.9). In keeping with these 
data, infection of DCs with pYV+∆yopE, pYV+∆yopH, pYV+∆yopM and pYV+∆yopT 
resulted in reduced upregulation of MHC class II, CD80, CD86 and CD54 (data not 
shown). Together these results suggest that wild type Y. enterocolitica (pYV+) 
inhibits maturation of DCs and that YopP accounts for this effect. 
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Fig. 3.9: Expression of MHC class II and co-stimulatory molecules by DCs after infection 
with Y. enterocolitica 
.DCs were incubated with the indicated strains of Y  enterocolitica. 3h post infection cells 
were stained for MHC class II, CD86, CD80 and CD54 (ICAM-1) (thick lines) or isotype-
matched control IgG (thin lines) and analysed by flow cytometry gating on the propidium 
iodide negative population. In the histograms the differences between the mean 
fluorescence intensities (MFI) values of specific antibodies to isotype controls are 
indicated. The diagrams show mean fluorescence intensity (MFI) values + SD of 3 
independent experiments. Statistically significant differences are indicated. 
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3.4 Cytokine production after infection of DCs with Y. 
enterocolitica  
To analyse whether cytokine release by mouse DCs is altered after infection with Y. 
enterocolitica, DCs were exposed to Y  enterocolitica wild type and mutant strains as 
described above and the cytokines IL-12, IL-10, KC and TNF-α were determined in 
culture supernatants by ELISA (Fig. 3.10).  
.
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Fig. 3.10: Production of IL-12, IL-10, KC and TNF-α by DCs after infection with                
Y. enterocolitica 
DCs were incubated with LPS (1µg/ml) or with the indicated strains of Y. enterocolitica. 
Gentamicin (100 µg/ml) was added 1 h after infection. 3 h (KC) or 23 h (IL-12, IL-10 and 
TNF-α) later, supernatants were harvested and analysed by ELISA. Data represent the 
means + SD of three independent experiments. Statistically significant differences are 
indicated. 
 
Infection of DCs with wild type Yersinia (pYV+) did not result in IL-12 secretion. In 
contrast, IL-12 secretion was induced by LPS, plasmid-cured (pYV-) or YopP-deficient 
(pYV+∆yopP) mutant strains of Y. enterocolitica. While maximum IL-12 
concentrations were observed after treatment of DCs with LPS and YopP-deficient 
(pYV+∆yopP) Yersinia mutant strain, the highest concentration of IL-10 was detected 
after infection with plasmid-cured Yersinia  (pYV-). This was significantly higher 
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compared to incubation with LPS or heat-killed Yersinia suggesting a role of invasin 
or Yersinia LPS in stimulating DCs to produce IL-10. No secretion of IL-10 was 
observed in DCs infected with wild type Yersinia (pYV+), in contrast to DCs infected 
with YopP-deficient Yersinia mutant strain (pYV+∆yopP). 
IL-8 is known to attract neutrophil granulocytes and also to contribute to T 
lymphocyte attraction (203). We analysed whether Y. enterocolitica may also affect 
the ability of mouse DCs to secrete KC, the mouse equivalent of IL-8. As shown in 
Fig. 3.10, incubation of DCs with LPS or Yersinia mutant strains (pYV-, hk pYV+, 
pYV+∆yopP) resulted in increased secretion of KC. In contrast, secretion of KC was 
not increased following infection with wild type Y. enterocolitica (pYV+). Similar 
results were observed regarding the release of TNF-α after Yersinia infection. 
Interestingly, maximum TNF-α was observed in DCs treated with the YopP-deficient 
mutant strain (pYV+∆yopP) (Fig 3.10). In keeping with these data, infection of DCs 
with pYV+∆yopE, pYV+∆yopH, pYV+∆yopM or pYV+∆yopT completely inhibited 
secretion of IL-12, IL-10, KC, and TNF-α  (data not shown) comparable with the wild 
type Y. enterocolitica strain (pYV+). Taken together, these results indicate that Y. 
enterocolitica suppresses cytokine production in DCs predominantly via the action of 
YopP. 
 
3.5 NF-κB activation after infection of DCs with Y. 
enterocolitica  
The transcription factor NF-κB promotes transcription of various immune response 
genes including those encoding MHC class II, costimulatory molecules (e.g., CD80, 
DC86) and cytokines (e.g., IL-12, TNF-α) (156). While Y. enterocolitica invasin 
protein was found to activate NF-κB in epithelial cells (181), YopP inhibits the 
activation of NF-κB, which, in concert with other effects, causes apoptosis of mouse 
macrophages (166). Therefore, we wanted to know whether Y. enterocolitica affects 
NF-κB activation in DCs. To address this, activation of NF-κB was analysed 
performing eletrophoretical mobility shift assays (EMSA) of nuclear extracts from DCs 
infected with wild type or different mutant strains of Y. enterocolitica (Fig. 3.11). 
Nuclear extracts showed low NF-κB-binding activity in untreated DCs. Infection with 
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plasmid-cured mutant strain (pYV-) or LPS increased NF-κB binding activity in DCs at 
all indicated time points.  
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Fig. 3.11: Y. enterocolitica induces a transient activation of NF-κB in DCs 
Time course of Yersinia-induced NF-κB activation. DCs were incubated with LPS (1µg/ml) 
or with the indicated strains of Y. enterocolitica. After 30, 60 and 90 min nuclear extracts 
were prepared and analysed in gel shift experiments with 32P-labelled probes for NF-κB 
consensus.  
 
Infection with wild type Y. enterocolitica (pYV+) led to an increased NF-κB binding 
activity 30 and 60 min after infection, but 90 min after infection NF-κB binding 
activity declined to backround levels. Upon infection with YopP-deficient Y. 
enterocolitica (pYV+∆yopP) NF-κB binding activity was also detectable above 
backround level 90 min after infection (Fig. 3.11).  
 
Before stimulation, NF-κB is retained in the cytoplasm in an inactive from due to its 
binding to the inhibitor (IκB) proteins. In response to LPS or other stimuli, IκB is first 
phosphorylated and then ubiquitinylated and targeted for the proteasome for 
degradation. This allows NF-κB to translocate to the nucleus and activate 
transcription of target genes. Therefore, western blot analyses of IκB were 
performed with DCs infected with different strains of Y. enterocolitica. High IκB-α 
concentrations were observed under control conditions at all indicated time points. 
Less IκB-α concentrations were observed when DCs were incubated either with LPS 
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or with Y. enterocolitica mutant strain pYV- 15 to 60 min after infection, indicating 
degradation of IκB-α (Fig. 3.12). Upon infection with YopP-deficient Y. enterocolitica 
(pYV+∆yopP) IκB-α concentrations declined from 30 to 45 min, but increased 60 min 
after infection. In contrast, upon infection with wild type Y. enterocolitica (pYV+) IκB-
α degradation was hardly observed. Since IκB-β concentrations were not changed by 
infection with Yersinia, the alteration of nuclear NF-κB activity appeared to be caused 
predominantly by changes in IκB-α. Taken together, these results indicate an 
inhibited activation of NF-κB in DCs infected with Y. enterocolitica (pYV+), which is 
mediated by YopP. 
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Fig. 3.12: Y. enterocolitica-induced degradation of I-κB in DCs 
DCs were incubated with LPS (1µg/ml) or with the indicated strains of Y. enterocolitica. 
After 15, 30, 45 and 60 min cells were lysed and analysed in western blot experiments 
probed for I-κBα  (upper panel) and I-κBβ (lower panel). Results are representative of 
three experiments. 
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3.6 Y. enterocolitica inhibits antigen uptake and processing 
in DCs 
To analyse whether the capacity of DCs to take up and process antigens is impaired 
by Y. enterocolitica, proliferation assays were performed using Ova peptide as well as 
Ova protein as antigens. Ova peptide can be loaded directly onto MHC class II 
molecules on the cell surface. Therefore, antigen uptake and processing of Ova 
peptide by DCs is not required for its presentation by MHC class II molecules to T 
cells, whereas for the presentation of Ova protein by MHC class II molecules antigen 
uptake and processing is necessary.  
 
Fig. 3.13: T cell proliferation after co-culture of DCs infected with different Yersinia 
mutant strains and pulsed with either Ova peptide or Ova protein 
abelled CD4+ T 
Uninfected DCs pulsed with either Ova peptide (Fig. 3.13A) or Ova protein (Fig. 
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DCs were incubated with the indicated mutant strains of Y. enterocolitica, then pulsed 
with Ova peptide (A) or Ova protein (B) for 2h and co-cultured with CFSE l
cells from Ova TCR transgenic DO11.10 mice. 4 days later T cell proliferation was 
analysed by flow cytometry. 
 
3.13B) and incubated with Ova-specific CD4+ T cells both led to a high proliferation 
of the T cells. Infection of DCs with wild type Yersinia (pYV+) completely abolished 
the capacity of DCs pulsed with Ova protein to activate T cells (Fig 3.13B). In 
contrast, a high T cell proliferation was observed when DCs were infected with wild 
type Yersinia (pYV+) and pulsed with Ova peptide. The proliferation rate of Ova-
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specific CD4+ T cells co-cultured with DCs either infected with the plasmid-cured Y.
enterocolitic
 
t
.6.1 Y. enterocolitica inhibits uptake of OVA-FITC by DCs 
ake DCs were 
t 37°C analysed by FACS revealed an increase 
tant strains (pYV-, 
a (pYV-) mutant strain or the heat-killed Y. enterocolitica (hk pYV+) wild 
ype strain and pulsed with Ova peptide was more or less comparable to DCs pulsed 
with Ova protein (Fig. 3.13). These results indicate, that Yersinia affects antigen 
uptake and processing of DCs. 
 
3
In order to investigate whether Y. enterocolitica inhibits antigen upt
incubated with Ova-FITC and uptake of Ova-FITC was tracked both by FACS and 
fluororeader. It is well established that after uptake into early endosomes the 
antigens are transported to the late endosomes and lysosomes (126). During the 
transport the pH within the vacuoles decreases from 7 to 5. The excitation of the 
fluorescent dye FITC is highly dependent on pH between 4 to 8. Consequently, Ova-
FITC located in early endosomes results in bright fluorescence by FACS analyses 
while Ova-FITC located in lysosomes should reveal lower fluorescence signals. To 
overcome this problem lysates of DCs incubated with Ova-FITC were adjusted to pH 
9 by means of lysis buffer and analysed by fluororeader, which should result in bright 
fluorescence. Consequently, Ova-FITC located in both endosomes and lysosomes 
should be detectable by fluororeader. 
A time course of Ova uptake by DCs a
in Ova-FITC uptake up to 30 min reaching a plateau at 40 min (data not shown). 
Therefore the following experiments were performed by incubating the DCs for 30 
min with Ova-FITC. Ova-FITC was rapidly internalised by DCs incubated at 37°C but 
not at 0°C resulting in a bright fluorescence after 30 min observed by flow cytometry 
and fluoreader (Fig. 3.14). Unspecific binding of OVA-FITC to the cell surface was 
assessed by incubating the DCs with Ova-FITC for 30 min on ice.  
DCs were infected with Y. enterocolitica wild type (pYV+) and mu
pYV+∆yopP) 1 h prior to incubation with Ova-FITC and subjected to FACS and 
fluorometric analyses. Fig. 3.14A demonstrates that Y. enterocolitica pYV+, but not 
the plasmid-cured pYV- mutant strain, inhibits Ova-FITC uptake by 45% (p<0,05) 
suggesting that pYV encoded virulence factors inhibit antigen uptake in DCs. In DCs 
infected with YopP-deficient mutant strain (pYV+∆yopP) Ova-FITC uptake was not 
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inhibited (Fig. 3.14A), indicating that YopP is responsible for decreased antigen 
uptake in DCs infected with wild type Y. enterocolitica. 
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Fig. 3.14: Inhibition of antigen uptake by DCs by Y. enterocolitica  
DCs were infected with the indicated strains of Y  enterocolitica or incubated with LPS for 
1 h. Afterwards DCs were incubated in medium containing Ova-FITC and gentamicin for 
30 min at 37°C and washed. Unspecific binding was assessed by incubating the DCs with 
Ova-FITC for 30 min on ice. (A) DCs were stained with an antibody against CD11c, and 
analysed by flow cytometry. Numbers shown in dot blots indicate percentages of cells in 
the upper two quadrants. The histograms show Ova-FITC uptake by CD11c
.
 
+ cells with 
mean fluorescence intensity (MFI) values. (B) DCs were lysed and analysed by 
fluorometer. Ova-FITC uptake by fluorometer is shown by arbitrary units. Data represent 
mean values + SD of 3 individual experiments and * indicate significant differences (P < 
0,05) compared to the positive control (37°C). 
 
In comparison to the results obtained by flow cytometry uptake of Ova-FITC by DCs 
incubated with LPS or infected with the YopP-deficient mutant strain of Y.
enterocolitica (pYV+∆yopP) was reduced by 50% when analysed by fluororeader (Fig. 
3.14B). Infection of DCs with the wild type strain and the plasmid-cured mutant 
strain of Y. enterocolitica revealed an inhibition of Ova-FITC uptake by 90% and 
70%, respectively (Fig. 3.14B). In summary, similar results were obtained by flow 
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cytometry and fluororeader except for the fact that the differences in Ova-FITC 
uptake by DCs incubated with LPS or infected with different mutant strains of Y.
enterocolitica compared to the positive control were higher when analysed by 
fluororeader than by flow cytometry. These data confirm the hypothesis that by flow 
cytometry the presence of Ova-FITC in lysosomes of DCs cannot by determined. In 
keeping with these data, infection of DCs with pYV
 
+∆yopE, pYV+∆yopH, pYV+∆yopM 
and pYV+∆yopT resulted in reduced Ova-FITC uptake (data not shown) comparable 
with the wild type Y. enterocolitica strain (pYV+). As a control, DCs were treated with 
LPS for 1 h and then incubated with Ova-FITC. The results demonstrate that LPS 
treatment reduces uptake of Ova-FITC up to 15%, which is in agreement with the 
concept that activation of DCs results in maturation accompanied by down-regulation 
of antigen uptake.  
 
3.6.2 MAP kinases are involved in antigen uptake by DCs 
In addition to NF-κB signalling, YopP inhibits the MAP kinase (MAPK) signalling 
pathway by interacting directly with several MAP kinase kinases (MKK) preventing 
their activation (141,142). However, it was not yet known whether NF-kB or MAPKs 
activation play a role in uptake of antigens in DCs. Previous work provided evidence 
that selective activation of p38 MAPKs increases endocytic rates in HeLa and BHK 
cells and suggested that activation of p38 MAPKs allows a more efficient 
internalisation of cell surface components (36). From this data we hypothesized that 
there might be a link between the activation of MAPKs and the mechanisms 
controlling antigen internalisation. To investigate whether MAPKs are involved in 
antigen uptake, DCs were pre-incubated with the inhibitors SP600125 (JNK), 
PD98059 (MEK1/2), and SB202190 (p38), or a mixture of these three inhibitors, 
incubated with Ova-FITC and analysed by FACS and fluororeader (Fig. 3.15 A and B, 
respectively). Incubation of DCs with inhibitors of JNK, MEK1/2, and p38 reduced 
antigen uptake by 20-35%. Combination of all three inhibitors reduced antigen 
uptake by 50-65%. These results suggest that MAPK play an important role in 
antigen uptake by DCs. The inhibitors were dissolved in DMSO. To exclude effects of 
DMSO on antigen uptake of Ova-FITC by DCs the cells were treated with similar 
amounts of DMSO compared to MAPKs inhibitors. The results obtained with DMSO 
were comparable to the positive control at 37°C.  
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Fig. 3.15: MAPKs are involved in antigen uptake by DCs 
DCs were incubated with different MAPK inhibitors [20 µM SP600125 (JNK), 50 µM 
PD98059 (MEK1/2) and 2 µM SB202190 (p38)] 30 min prior to incubation with Ova-FITC. 
Then the fluorescence taken up by the cells was analysed by flow cytometry (A) or by 
fluororeader (B). Ova-FITC uptake is shown as percentages of total uptake of the 
untreated CD11c+ cells. Data represent mean values + SD of 3 individual experiments and 
* indicate significant differences (P < 0,05) compared to the positive control (37°C). 
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Fig. 3.16: MAPK inhibitors complement inhibition of antigen uptake by DCs infected with 
YopP-deficient Yersinia mutant strain 
DCs were infected with the YopP mutant strain pYV+∆yopP (left panel) or the wild type 
strain pYV+ (right panel) for 1h. 30 min later MAPK inhibitors [20 µM SP600125 (JNK), 50 
µM PD98059 (MEK1/2) and 2 µM SB202190 (p38)] were added to the cells for 30 min. 
After incubation with Ova-FITC DCs were washed, stained with an antibody against CD11c 
and the fluorescence taken up by the cells was analysed by flow cytometry. OVA-FITC 
uptake is shown as percentages of total uptake of the untreated CD11c+ cells. Data 
represent mean values + SD of 3 individual experiments and * indicate significant 
differences (P < 0,05) compared to DCs infected with pYV+∆yopP. 
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In order to complement the function of YopP, DCs were infected with YopP-deficient 
mutant strain of Y. enterocolitica (pYV+∆yopP) and simultaneously treated with single 
MAPK inhibitors or a mixture of the three inhibitors and analysed for Ova-FITC 
uptake. The results demonstrate that the addition of MAPK inhibitors to DCs infected
with Y. en erocolitica pYV
 
t +∆yopP leads to a reduction of antigen uptake (Fig. 3.16 A). 
In contrast, DCs infected with Y. enterocolitica pYV+ and treated subsequently with 
MAPK inhibitors showed no further reduction in Ova-FITC uptake (Fig. 3.16 B). 
Therefore, inhibition of Ova-FITC uptake by wild type Y. enterocolitica largely 
depends on YopP and its inhibitory effect on MAPK signalling cascades. 
 
3.6.3 Ova-FITC uptake by DCs is dependent on actin polymerisation but 
independent of activation of small GTPases 
Endocytosis in DCs is controlled by small GTPases. Cdc42 was shown to affect 
antigen uptake in mouse bone-marrow derived DCs, while Rac1 is involved in 
endocytosis of mouse splenic DCs (69,220). Uptake of FITC-labelled dextran 40, 
which was shown to be internalised mainly by clathrin-mediated endocytosis (116), 
was inhibited by the Rho GTPase inhibitor toxin B of Clostridium difficile (190). Ova-
FITC is internalised by DCs via both chlathrin-mediated endocytosis and 
macropinocytosis (116). Macropinocytosis is highly dependent on actin 
polymerisation (3) and activation of Rho GTPases (56,57) and therefore, can be 
blocked by cytochalasin D and toxin B from C. difficile, respectively. Clathrin-
mediated endocytosis, previously referred to as receptor-mediated endocytosis (43), 
comprises endocytosis of receptors like low-density-lipoprotein receptor (LDLR), 
transferrin receptor (TfR), macrophage mannose receptor (MMR), Fc receptors, and 
members of the C-type lectin family (59,152,172,218). Mannan is used to 
competitively bind to the MMR during Ova-FITC incubation (172). It was shown that 
actin polymerisation and activation of Rho GTPases is not generally required for 
clathrin-mediated endocytosis (102,127). To address which of these pathways is 
involved in the system used in this thesis, inhibitors of both pathways were used and 
uptake of Ova-FITC was determined (Fig. 3.17).  
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Fig. 3.17: Internalisation of Ova-FITC by DCs depends on actin cytoskeleton but does not 
require the activity of small GTPases. 
DCs were incubated with mannan, cytochalasin D (CyD) or C. difficile toxin B 10463 
(TcdB) prior to incubation with Ova-FITC and analysed by FACS (A) and confocal 
microscopy (B). (A) After incubation with Ova-FITC cells were washed, stained with an 
antibody against CD11c, and the fluorescence taken up by the cells was analysed by flow 
cytometry. Ova-FITC uptake by untreated CD11c+ cells was set 100%. Data represent 
mean values + SD of 3 individual experiments and * indicate significant differences (P < 
0,05) compared to the (A) positive control (37°C) and (B) pYV+∆yopP. (C) Confocal 
microscopy pictures were kindly provided by I. Soldanova. Green: Ova-FITC; red: 
phalloidin-TRITC. 
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The most important receptor for the uptake of dextran and mannosylated proteins in 
human DCs is the macrophage mannose receptor (172). The results pictured in Fig. 
3.17 indicated that addition of mannan, which competitively binds to the mannose 
receptor, does not significantly inhibit Ova-FITC uptake in DCs, indicating that Ova-
FITC uptake via the mannose receptor does not play an important role in mouse 
DCs. Treatment of DCs with cytochalasin D reduced Ova-FITC uptake to 50-60% 
(Fig. 3.17A). In contrast, incubation of DCs with C. difficile toxin B 10463 (TcdB), 
which inhibits the Rho GTPases RhoA, Rac1 and Cdc42 had no significant effect on 
Ova-FITC uptake, although with both inhibitors the cytoskeleton of DCs was 
damaged as demonstrated by confocal microscopy with phalloidin-TRITC staining 
(Fig. 3.17B). These results indicate that Ova-FITC uptake by DCs is dependent on 
actin polymerisation but independent of the activation of small GTPases. 
Interestingly, CyD additionally reduced Ova-FITC uptake in DCs infected with Y. 
enterocolitica pYV+∆yopP suggesting Yersinia inhibits a MAPK dependent pathway for 
endocytosis and that this pathway is to some degree actin independent (Fig. 3.17 B).  
 
3.6.4 Y. enterocolitica and MAPK inhibitors reduce clathrin-mediated 
endocytosis  
To analyse whether clathrin-mediated endocytosis is inhibited by Y. enterocolitica 
transferrin (Tf), which is selectively taken up by the transferrin-receptor (TfR), was 
used as a marker for clathrin-mediated endocytosis. Clathrin-mediated endocytosis of 
Tf-TfR complex is constitutively active in DCs. The complex is taken up into early 
endosomes, where Tf is released from the receptor, which is rapidly recycled to the 
cell surface.  
DCs were infected with different strains of Y. enterocolitica, incubated with Tf-FITC 
and subsequently analysed by flow cytometry (Fig. 3.18). The wild type Y. 
enterocolitica strain (pYV+) inhibited uptake of Tf-FITC in DCs by 35%, compared to 
the YopP-deficient mutant strain (pYV+∆yopP), which increased Tf-FITC uptake in 
DCs by 45%. Incubation of DCs with different MAPK inhibitors affecting JNK, 
MEK1/2, or p38 reduced Tf-FITC uptake by 20-40% indicating that MAPK play also 
an important role in internalisation of the transferrin receptor. 
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Fig. 3.18: Receptor-mediated endocytosis of transferrin by DCs is reduced by Y. 
enterocolitica and inhibitors of MAPK. 
DCs were incubated with different MAPK inhibitors [SP600125 (JNK), PD98059 (MEK1/2) 
and SB202190 (p38)], cytochalasin D (CyD) or Clostridium diffificle toxin B (TcdB) or 
infected with Yersinia wild type (pYV+) or with the YopP-deficient mutant strain 
(pYV+∆yopP). After incubation with Tf-FITC DCs were washed, stained with an antibody 
against CD11c, and the fluorescence taken up by the cells was analysed by flow 
cytometry. Tf-FITC uptake is shown as percentage of total uptake by untreated CD11c+ 
cells. Data represent mean values + SD of 3 individual experiments and * indicate 
significant differences (P < 0,05) compared to untreated DCs. 
 
Cytochalasin D reduced Tf-FITC uptake by DCs to 50% (Fig. 3.18), whereas 
inhibition of Rho GTPases by toxin B had no significant effect on Tf-FITC uptake (Fig. 
3.18). From these results one can conclude that Y. enterocolitica inhibits antigen 
uptake via clathrin-mediated endocytosis. 
 
3.6.5 Y. enterocolitica inhibits macropinocytosis in a YopP-independent 
manner 
Immature, but not mature, DCs constitutively internalise high amounts of soluble 
antigen via macropinocytosis. Lucifer yellow (LY) is internalised by DCs via 
macropinocytosis and can easily be analysed by its property to emit fluorescence. To 
analyse the influence of Y. enterocolitica on macropinocytosis, DCs were infected 
with different strains of Y. enterocolitica, incubated with LY, and analysed by flow 
cytometry (Fig. 3.19). TcdB inhibits RhoA, Rac1, and Cdc42 as well as CyD, which 
inhibits actin polymerisation, were used as positive controls to block 
macropinocytosis. In fact, macropinocytosis in DCs is highly dependent on the action 
of the RhoGTPases Cdc42, and Rac1 as well as actin polymerisation (69,220). The 
results revealed that the uptake of LY in DCs incubated with TcdB and CyD was 
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reduced to 90 and 60%, respectively, suggesting that actin polymerisation and 
activation of Rho GTPases is crucial for uptake of LY in DCs. The wild type Y. 
enterocolitica strain (pYV+) inhibited uptake of LY by 70% (Fig. 3.19). However, 
similar results were also obtained with the YopP-deficient mutant strain 
(pYV+∆yopP), indicating that inhibition of macropinocytosis by Y. enterocolitica is 
YopP independent. In agreement with this result, incubation of DCs with a mixture of 
inhibitors of MAPKs JNK, MEK1/2, and p38 did not significantly reduce uptake of LY 
suggesting that MAPKs do not play an important role in macropinocytosis of mouse 
DCs.  
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Fig. 3.19: Macropinocytosis of lucifer yellow (LY) in DCs is reduced by Y. enterocolitica 
but not by inhibitors of MAPK. 
DCs were incubated with a mixture of different MAPK inhibitors [SP600125 (JNK), 
PD98059 (MEK1/2) and SB202190 (p38)], cytochalasin D (CyD) or Clostridium difficile 
toxin B (TcdB) or infected with Yersinia wild type (pYV+) or with the YopP-deficient 
mutant strain (pYV+∆yopP). After incubation with LY DCs were washed, stained with an 
antibody against CD11c, and the fluorescence taken up by the cells was analysed by flow 
cytometry. LY uptake is shown as mean fluorescence intensities (MFI) and the data are 
representative of 3 individual experiments. 
 
 
Table 3: Inhibition of uptake of Ova-FITC, transferrin-FITC and lucifer yellow by various 
inhibitors or Y. enterocolitica 
 
 Mannan CyD TcdB MAPKs pYV+ YopP 
Ova-FITC - + - + + + 
Tf-FITC ≡ clathrin-
mediated endocytosis 
- + - + + + 
LY ≡ macropinocytosis n.d. + + - + - 
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From the aforementioned results it can be concluded that: (i) uptake of Ova-FITC by 
mouse DCs is mediated by both clathrin-mediated endocytosis (major mechanism) 
and macropinocytosis (minor mechanism); (ii) MAPKs are involved in clathrin-
mediated endocytosis; (iii) Y. enterocolitica inhibits both clathrin-mediated 
endocytosis and macropinocytosis; and (iv) YopP of Y. enterocolitica inhibits clathrin-
mediated endocytosis. 
 
3.6.6 Inhibition of Ova uptake by Y. enterocolitica and MAPK inhibitors 
is independent of TLR2 and TLR4 
Recently it was shown by West et al. (221) that TLR ligands acutely stimulate 
macropinocytosis of Dextran-FITC. This effect was observed only transiently at 30 to 
45 min upon TLR activation and a pulse of 10 min with Dextran-FITC and requires 
p38 and ERK activation. To address whether the reduced uptake of Ova by DCs 
incubated with Y. enterocolitica or MAPK inhibitors is due to the inhibition of MAPKs 
activated via TLR2 and TLR4, we analysed Ova-FITC uptake by DCs from TLR2-/- x 
TLR4-/- mice. Wild type Y. enterocolitica (pYV+) inhibited Ova-FITC uptake by DCs 
from both wild type (C57BL/6x129Sv) and TLR2-/-xTLR4-/- mice to 70 and 50%, 
respectively (Fig. 3.20). No significant reduction of Ova-FITC uptake was observed 
with DCs from both mouse strains infected with the YopP-deficient mutant strain 
(pYV+∆yopP). Moreover, both DCs from wild type mice (C57BL/6x129Sv) and TLR2-/-
xTLR4-/- mice incubated with a mixture of MAPK inhibitors of JNK, MEK1/2, and p38 
showed a reduced Ova uptake by 65%. These results are similar to those obtained 
from DCs of BALB/c mice (Fig. 3.14 and 3.15) and demonstrate, that inhibition of 
Ova uptake by DCs infected with Y. enterocolitica or incubated with inhibitors of 
MAPKs is independent of the TLR2 and TLR4 signalling pathway. Similar results were 
observed using DCs from MyD88-/- and TRIF-/- mice (data not shown). 
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Fig. 3.20: Y. enterocolitica and inhibitors of MAPKs reduce uptake of Ova-FITC by DCs 
from TLR2-/-xTLR4-/- mice. 
DCs from wild type C57BL/6x129Sv (A) and TLR2-/-xTLR4-/- (B) mice were incubated with 
LPS, a mixture of different MAPK inhibitors [SP600125 (JNK), PD98059 (MEK1/2) and 
SB202190 (p38)], or infected with Yersinia wild type (pYV+) or with the YopP-deficient 
mutant strain (pYV+∆yopP). After incubation with Ova-FITC DCs were washed, stained 
with an antibody against CD11c, and the fluorescence taken up by the cells was analysed 
by flow cytometry. Ova uptake is shown as mean fluorescence intensities (MFI) and the 
data are representative of 3 individual experiments. 
 
3.6.7 Inhibition of MAPKs in DCs reduces their ability to stimulate T 
cells  
The results obtained in chapter 3.6.2 and 3.6.4 revealed that inhibition of MAPK 
pathways leads to reduced uptake of Ova as well as Tf. To address whether this 
reduced antigen uptake has any functional consequences on the capacity of DCs to 
stimulate T cells proliferation assays were performed. For this purpose DCs were 
incubated with different MAPK inhibitors prior to incubation with Ova protein. Then, 
CFSE-labelled T cells were added and T cell proliferation was determined by FACS. 
Fig. 3.21 shows that T cell proliferation after co-culture of DCs incubated with MAPK 
inhibitors was inhibited (19 – 35% proliferated T cells) compared to the positive 
control (47% proliferated T cells). Inhibition of all three MAPK signalling pathways 
led to an almost complete inhibition of T cell proliferation compared to untreated 
DCs. 
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Fig. 3.21: T cell proliferation after co-culture of DCs incubated with MAPK inhibitors 
DCs were incubated with the indicated inhibitors of MAPKs (30 min), then pulsed with Ova 
for 2 h, washed, and co-cultured with CFSE labelled CD4+ T cells from Ova TCR transgenic 
DO11.10 mice. 4 days later T cell proliferation was analysed by flow cytometry. Numbers 
indicate the percentage of unproliferated cells. Results are representative of three 
experiments.  
 
Therefore, one can conclude that inhibition of MAPKs, which leads to a reduced 
uptake of Ova, also affects the ability of DCs to stimulate T cells. However, it cannot 
be excluded that inhibition of MAPKs has additional effects on DCs, which may also 
affect their ability to trigger T cell proliferation. 
 
3.6.8 Y. enterocolitica reduces the amount of enzymatically active 
cysteine proteases in DCs 
Cathepsins are known to be essential for antigen degradation as well as degradation 
of the Ii to process new MHC class II molecules for peptide loading. To address 
whether pathogenicity factors of Y. enterocolitica are able to inhibit the antigen 
processing machinery of DCs, the amount of enzymatically active cathepsins (Cats) 
was analysed by active site-directed labelling. For this purpose cell organelles of DCs 
were purified after infection with Y. enterocolitica. The cell organelles were lysed and 
incubated with a biotinylated probe directly binding to the catalytically active centre 
of cysteine proteases. Proteins were separated by SDS-PAGE and active cathepsins 
visualized by streptavidin blotting. Lysates of monocytes (Mo), from which the 
sequences of the proteins were determined, were used to assign the bands on the 
blots to the specific cathepsins. As further controls for the active-site-directed 
labelling lysates were either boiled or incubated with inhibitors of all cysteine 
proteases (E64), for Cat B (LHVS) or for Cat S (Ca074) prior to incubation with the 
active-site-directed probe (Fig. 3.22). 
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Fig. 3.22: Reduced amount of enzymatically active cathepsins in DCs after infection with 
Y. enterocolitica 
DCs were incubated with LPS or infected with the wild type strain of Y. enterocolitica for 1 
or 3 h. Then the organelles of DCs were prepared, lysed and incubated with a biotinylated 
active-site directed probe for cysteine proteases. Proteins were separated by SDS-PAGE 
and active proteases were visualised by streptavidin blotting. The broad-spectrum 
inhibitor for cysteine proteases E64 as well as the inhibitors of Cat S (Ca074) and Cat B 
(LHVS) were added 30 min prior to labelling.  
 
The amount of all active cathepsins specific for this probe was reduced 3 h after 
infection of DCs with the wild type strain of Y. enterocolitica (Fig. 3.22) compared to 
1 h post infection or untreated DCs. LPS was used as a positive control leading to 
maturation of DCs and therefore activation of proteases involved in antigen 
degradation and MHC class II maturation. In agreement with this the amount of 
active cathepsins highly increased from 1 h to 3 h incubation with LPS compared to 
untreated DCs. From these data it can be concluded that the amount of active 
cathepsins is not increased in DCs infected with Y. enterocolitica. pYV+ rather 
decreased the amount of active cathepsins in DCs although they encounter LPS upon 
engagement by Y. enterocolitica. 
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Fig. 3.23: Reduced amount of enzymatically active cathepsins in DCs after infection with 
different mutant strains of Y. enterocolitica 
 DCs were incubated with LPS or infected with the indicated mutant strains of Y.
enterocolitica for 3 h. Then the organelles of DCs were prepared, lysed and incubated 
with a biotinylated active-site directed probe for cysteine proteases. Proteins were 
separated by SDS-PAGE and active proteases were visualised by streptavidin blotting.  
 
To analyse which pathogenicity factor of Y. enterocolitica leads to the reduced 
amount of active cathepsins, DCs were infected with different mutant strains of Y. 
enterocolitica. Fig. 3.23 shows that infection of DCs with the plasmid-cured mutant 
strain (pYV-) led to an increase of active cathepsins in DCs comparable to LPS. 
Similar results were obtained for the YopH (pYV+∆yopH) and YopP (pYV+∆yopP) 
deficient mutants in this experiment. In 9 of 17 experiments the active site-directed 
labelling with YopP revealed an increase in the amount of active cathepsins in DCs 
infected with the YopP-deficient mutant strain, while in 8 of 17 experiments no 
changes were observed. For DCs infected with the YopH deficient mutant strain an 
increase in the amount of active cathepsins was observed in 2 of 4 experiments. In 
contrast, in DCs infected with the YopE and YopT deficient mutant strains the 
amount of active cathepsins did not increase. These data indicate that plasmid-
encoded virulence factors inhibit the increase of active cathepsins in DCs, but it is not 
clear which Yop is responsible for this effect. 
To exclude that this observation is due to non-specific features of the induction of 
cell death in DCs by YopP of Y. enterocolitica, active site-directed labelling 
experiments were performed by incubating DCs with staurosporine as an inductor of 
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apoptosis and Z-VAD-fmk as a pan-caspase inhibitor preventing apoptosis. In 
contrast to DCs infected with Y. enterocolitica, DCs incubated with staurosporine 
highly upregulated the amount of all active cathepsins (Fig. 3.24), indicating that 
induction of apoptosis in DCs does not lead to a reduced activation of cysteine 
proteases. After incubation of DCs with Z-VAD-fmk nearly no active cathepsins could 
be observed, suggesting that Z-VAD-fmk may directly interact with the catalytically 
active centre of cathepsins.  
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Fig. 3.24: Reduced amount of enzymatically active cathepsins in DCs after infection with 
Y. enterocolitica is independent of cell death 
DCs were either incubated with staurosporine, with pan-caspase inhibitor Z-VAD-fmk or 
infected with the wild type strain of Y. enterocolitica. 3 h post infection organelles of DCs 
were prepared, lysed and incubated with a biotinylated active site-directed probe for 
cysteine proteases. Proteins were separated by SDS-PAGE and active proteases were 
visualised by streptavidin blotting.  
 
One possibility for the reduced amount of catalytically active cathepsins could be that 
Y. enterocolitica reduces the total amount of cathepsins. To address this, DCs were 
infected with Y. enterocolitica and different mutant strains and western blot analyses 
were performed using an antibody for cathepsin S. The data shown in Fig. 3.25 
demonstrated that no difference in the amount of total cathepsin S was observed in 
DCs infected with Y. enterocolitica wild type strain (pYV+), the plasmid-cured mutant 
strain (pYV-), or any mutant strain deficient for a single Yop compared to untreated 
DCs or DCs incubated with LPS (Fig. 3.25). 
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Fig. 3.25: Expression of cathepsin S in DCs after infection with Y. enterocolitica 
DCs were infected with the indicated strains of Y. enterocolitica. 3h post infection 
organelles of DCs were prepared, lysed and proteins were separated by SDS-PAGE and 
probed for the expression of cathepsin S by immunoblot.  
 
From these data it can be concluded that plasmid-encoded factors of Y. enterocolitica 
prevent the increase of active cathepsins and that this effect is independent of the 
induction of apoptosis in DCs by Y. enterocolitica. 
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4 Discussion 
CD4 T cells are essential to overcome Yersinia infection in mice (13). Therefore, APCs 
including DCs which present antigen to CD4 T cells via MHC class II molecules might 
play a crucial role in the defence against infection with Y. enterocolitica. Herein, it 
was elucidated whether and how Y. enterocolitica affects DCs in their ability to prime 
CD4 T cells.  
For the stimulation of CD4 T cells several conditions must be fulfilled by the DC: the 
antigenic peptide must be presented via MHC class II molecules, which requires 
antigen uptake, processing, and loading onto MHC class II molecules. For the 
formation of the immunological synapse co-stimulatory as well as adhesion molecules 
must be expressed on the cell surface in addition to MHC class II-peptide complexes. 
Furthermore, the production of cytokines like IL-12 and IL-10 is necessary to induce 
T cell effector differentiation. 
The present study demonstrates that Y. enterocolitica affects several important 
functions of mouse DCs including cell viability, maturation, cytokine production, 
antigen uptake as well as antigen processing. These alterations of DCs by Y. 
enterocolitica obviously contribute to the inhibited antigen-specific CD4 T cell 
stimulation observed in vitro. 
 
4.1 Y. enterocolitica inhibits the capacity of DCs to activate 
CD4 T cells 
Proliferation assays performed with DCs infected with Y. enterocolitica demonstrated 
that Y. enterocolitica completely blocks the capacity of mouse DCs to activate CD4+ T 
cells. In contrast, infection of DCs with heat-killed Yersinia and the plasmid-cured 
mutant strain (pYV-) hardly reduced T cell proliferation compared to the non-infected 
control DCs. Therefore, chromosomally encoded factors as well as Yersinia LPS do 
not contribute to inhibition of T cell proliferation observed with DCs infected with the 
Y. enterocolitica wild type strain (pYV+). Therefore, it can be concluded that the main 
factors leading to a complete inhibition of T cell proliferation observed are encoded 
by the virulence plasmid pYV. T cell proliferation assays performed with DCs infected 
with different Yersinia mutant strains deficient for a single Yop showed that deletion 
of YopP restored T cell proliferation comparable to that of DCs infected with the 
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plasmid-cured mutant strain. These data indicate an important role for YopP 
affecting the capability of DCs to promote T cell proliferation. However, in contrast to 
this, T cell proliferation was not reduced after infection of DCs using Yersinia mutant 
strains translocating only one Yop e.g. YopP. Analyses of these Yersinia mutants for 
secretion and translocation by western blot revealed that the Yops are translocated 
and that a defect in translocation of the Yops into the cytosol of the DCs can be 
excluded (data not shown). Moreover, infection with the Yersinia mutant 
translocating YopP only induced cell death in DCs (Fig. 3.8). Therefore, it is likely 
that inhibition of T cell proliferation by DCs infected with wild type Yersinia is not due 
to YopP alone, rather it is likely that YopP in concert with other Yops affects DCs’ 
functions. 
Recently, similar findings for YopP were observed in an in vivo infection model with 
attenuated Y. enterocolitica mutant strains lacking different Yops and translocating a 
fusion protein of YopE and the listerial antigen LLO by their TTSS. Trülzsch et al. 
could show, that a YopP mutant is able to induce a strong CD8 T cell response to the 
LLO antigen, whereas mutant strains lacking YopH, YopM, YopE or YopQ did not 
(206). From this observation they concluded that YopP inhibits the adaptive immune 
response of the host by suppressing the development of a CD8 T cell response in
vivo (206).  
 
 
In contrast to the findings herein, which demonstrate that live Y. enterocolitica and 
factors encoded by the virulence inhibit the ability of DCs to activate CD4 T cells, 
studies from Schoppet et al. revealed that infection of human immature DCs with Y. 
enterocolitica leads only to a transient suppression of T cell stimulation up to five 
days (178). In a second approach the authors could show that this transient effect is 
not dependent on viable bacteria (179). 
Effects on the ability of DCs to promote T cell proliferation have also been described 
for Salmonella enterica (39). This study reported that intracellular activities of S. 
enterica in DCs suppress antigen dependent T cell proliferation. This effect was 
dependent on the induction of inducible NO synthase by DCs and on the function of 
virulence genes in Salmonella pathogenicity island 2 (SPI2), a part of the Salmonella
chromosome encoding e.g. the type three secretion system (39). 
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4.2 YopP induces cell death of mouse DCs 
The most prominent effect of Y. enterocolitica on DCs was the induction of cell 
death. This observation is in contrast to a recent report that provided some evidence 
that human DCs do not undergo cell death after infection with Y. enterocolitica 
(178). These differences might be due to the different Yersinia serotypes which were 
used in the two studies. In the present study Y. en erocolitica serotype O:8 was 
used. This serotype is known to be a more effective inductor of apoptosis than 
serotype O:3 (168) which was used in the study from Schoppet et al. However, cell 
death is also observed in a Yersinia-infected mouse macrophage cell line (J774), and 
this effect is caused by YopP (53,169). Consistent with these results we found that in 
contrast to wild type Y. enterocolitica (pYV
t
+), a YopP-deficient mutant strain 
(pYV+∆yopP) does not induce death of DCs, whereas a mutant strain translocating 
selectively the effector protein YopP by its TTSS (pTTSSyopP+) was able to induce 
cell death in mouse DCs. Moreover, it was found that macrophages that had been 
pre-treated with LPS and thus have been rendered “tolerant” to further LPS 
stimulation, were much less susceptible to Yersinia induced cell death (169). 
Likewise, we found that mature DCs that had been pre-treated with LPS were less 
susceptible to Yersinia YopP induced cell death than immature DCs (data not shown). 
This suggests that beside macrophages DCs also undergo cell death upon interaction 
with pathogenic yersiniae, and YopP appears to be the most important factor for 
induction of DCs’ death.  
Exposure of DCs to Y. enterocolitica caused a decrease in the mitochondrial 
membrane potential, DNA fragmentation, and translocation of phosphatidylserine 
residues from the inner to the outer cellular membrane leaflet, strongly suggesting 
that Yersinia mediated death of DCs is predominantly caused by apoptosis. In the 
present study the frequency of apoptotic DCs 4 h after infection with Yersinia was 
similar to that observed in experiments with a mouse macrophage cell line (J774) 
(169). While macrophages were infected with Yersinia at a MOI of 50 for 90 min 
(169), the DCs used in this study were infected at a MOI of 10 for 60 min only. In 
our experiments higher MOIs caused a rapid and total disruption of DCs suggesting 
that mouse DCs are more susceptible to Yersinia-induced apoptosis than 
macrophages. In fact, we infected J774 mouse macrophages and DCs with Y. 
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enterocolitica in parallel, and 4 h later survival of macrophages was markedly higher 
than that of DCs (61% versus 35%; data not shown).  
In macrophages, YopP mediated inhibition of NF-κB activation appears to be involved 
in Yersinia-induced apoptosis (166). A biphasic NF-κB activation course was found in 
Yersinia-infected macrophages. NF-κB binding activity was observed after 30 min but 
was absent 90 min after Yersinia infection. In DCs a slight activation of NF-κB at 30 
and 60 min was observed even after infection with wild type Y. enterocolitica (pYV+), 
however, this signal declined markedly after 90 min. The faster prevention of NF-κB 
signalling in macrophages might result from the higher Yersinia MOI used for 
infection in the experiments carried out by Ruckdeschel et al. (166). Despite the fact 
that nuclear NF-κB activity was obtained for longer periods in Yersinia infected DCs 
than in macrophages, DCs turned out to be more susceptible to killing by Yersinia 
than macrophages. Therefore, at present it is not clear whether and to what extent 
prevention of NF-κB activation in DCs triggers apoptosis. 
Several other pathogens are also able to induce cell death upon interaction with 
phagocytes. The SPI-1 effector protein SipB of Salmonella enterica, translocated via 
a type III secretion system, was shown to activate caspase-1 in macrophages 
leading to rapid cell death by a mechanism that has features of both apoptosis and 
necrosis (133). A similar mechanism for the induction of apoptosis was observed in 
human macrophages infected with Shigella flexneri (83). Infection of human and 
mouse DCs with Listeria monocytogenes revealed similar differences for the two 
species as observed for Y. enterocolitica. In fact, infection of mouse DCs with L. 
monocytogenes induced apoptosis, prevented T cell proliferation, both events were 
conferred by listeriolysin (50,74) and were not obvious in human DCs infected with L. 
monocytogenes (143).  
Additionally, studies from Monack et al. revealed a role for YopJ, the analogue of 
YopP in Y. pseudotuberculosis, in the induction of apoptosis in CD11b+ (Mac-1+) cells 
in vivo (132). After oral inoculation the LD50 of a Y. pseudotuberculosis mutant 
deficient for YopJ increased 64-fold compared to the wild type strain. In fact, 5 days 
post infection with wild type Y. pseudotuberculosis 30% of Mac-1+ cells in the spleen 
were TUNEL positive, compared to 2% with the YopJ mutant strain. From these data 
they conclude that YopJ plays a role in the establishment of a systemic infection by 
inducing apoptosis. 
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Preliminary data from in vivo experiments in our group showed only low apoptotic 
CD11c+ cells in the spleen of mice either infected with wild type Yersinia or the YopP-
deficient mutant strain (data not shown). In addition we observed no significant 
difference in CFU in the liver after i.v. infection with the wild type Y. enterocolitica 
and the YopP mutant strain. Trültzsch et al. found that in mice the YopP mutant 
strain was slightly attenuated compared to the parental strain (2 fold lower CFU 
counts in the spleen of mice infected with the YopP mutant strain compared to the 
wild type pYV+) (207). This suggests a limited role of YopP for the pathogenicity of 
Y. enterocolitica in the experimental mouse infection model. 
Therefore, further experiments are necessary to address whether YopP of Y. 
enterocolitica plays a role in the induction of apoptosis and inhibition of priming CD4 
T cell responses in DCs in vivo. Furthermore, the mechanism by which YopP induces 
cell death in mouse DCs has to be elucidated. 
 
4.3 YopP inhibits maturation and cytokine production of DCs 
Another assumption of proper T cell activation capacity of DCs is the maturation, 
including upregulation of MHC class II molecules, costimulatory molecules like CD80, 
CD86, CD40 as well as adhesion molecules e.g. CD54 (ICAM-1).  
This study demonstrates that DCs infected with wild type Y. enterocolitica did not 
upregulate CD80, CD86 and CD54. Upregulation of MHC class II molecules in DCs 
infected with wild type Y. enterocolitica was also reduced compared to incubation of 
DCs with LPS or infection with the plasmid-cured mutant strain. This inhibited 
maturation of DCs observed after infection with Y. enterocolitica is mediated by 
YopP.  
Similar to our observations in DCs, it was also found that Y. pseudotuberculosis 
inhibits upregulation of costimulatory molecules such as B7.2 on the surface of B 
cells (223). The block of B lymphocyte activation resulted from the inhibition of early 
phosphorylation events of the B cell receptor-signalling complex. Yao et al. could 
show, that this effect was dependent on the production of YopH, a tyrosine 
phosphatase (223).  
Analyses of human DCs infected with Y. enterocolitica revealed a marked but 
transient down-regulation of MHC class II molecules on day 3 after infection, and 
down-regulation to a lesser extent for CD80 on day 5 (178). In contrast, within 24 h 
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infection, DCs upregulated CD83, and CD86 on day 3, which indicates maturation of 
DCs. One big difference to the data described herein is that the changes in surface 
molecule expression on human DCs were obvious 3 to 5 days post infection, whereas 
in mouse DCs the described inhibition of maturation was obvious 3 h post infection. 
As mentioned earlier, one possible explanation for these differences is the use of 
different Yersinia strains in both studies. In addition, the experiments from Schoppet 
et al. were performed using bacteria grown at 27°C over night without further 
incubation at 37°C. As Y. enterocolitica  incubation at 37°C induces the production of 
Yops (104), only chromosomally-encoded virulence factors were acting on the DCs in 
the experiments performed by Schoppet et al. 
Effects on DC maturation have also been described for other pathogens. It has been 
shown that Plasmodium falcipa um (209), Trypanosoma cruzi (211), and herpes 
simplex virus (171) prevent DC maturation. Adherence of P. falciparum-infected 
erythrocytes to DCs inhibits the maturation of these DCs. In the case of T. cruzi an 
unknown soluble factor is responsible for the suppressed maturation of DCs.  
r
In contrast, Mycobacterium tuberculosis (82), Streptococcus gordonii (44), and 
Chlamydia psittaci (139) induce activation and maturation of DCs. 
 
DCs release a number of cytokines upon exposure to bacterial LPS (76). Cytokines 
are key mediators of the immune responses and their release can activate cells of 
the innate and adaptive immunity. For example, IL-12, IL-18 and IL-23 can promote 
TH1 responses whereas IL-4 induces TH2 responses. IL-10 induces regulatory T cells. 
IL-12 is also able to activate NK cells and IL-8 recruits neutrophils to the site of 
infection. TNF-α  plays a major role in the inflammatory response by recruiting and 
activating monocytes and neutrophils. 
In addition to the inhibited upregulation of surface molecules on DCs necessary for 
the formation of the immunological synapse, this study shows that Y. enterocolitica 
suppresses cytokine production, including IL-12, IL-10, TNF-α, and KC by DCs. 
Again, this effect is mediated via the action of YopP. These results are consistent 
with previously published data for mouse macrophages and epithelial cells (177,183). 
For mouse macrophages it was shown that YopP of Y. enterocolitica as well as YopJ 
in Y. pseudotuberculosis suppress TNF-α production (30,142,167). In these cases 
both, the inhibition of the NF-κB and the MAPK signalling pathway leads to the 
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suppression of TNF-α. Schulte et al. showed that Yops of Y. enterocolitica inhibit IL-8 
production by human epithelial cells (181). 
The temporary activation of NF-κB in DCs observed after infection with wild type 
Yersinia (pYV+) might explain the difference between the slight upregulation of MHC 
class II molecules and the lack of costimulatory molecules and cytokine release. In 
contrast to cytokines and costimulatory molecules, preformed MHC class II molecules 
are abundant in intracellular compartments of non-activated DCs (96). While limited 
activation of DCs might be sufficient to stimulate the transport of preformed MHC 
class II molecules to the cell surface of DCs, de novo synthesis of cytokines may 
require a prolonged period of cell activation. Rescigno et al. showed that LPS induced 
maturation of DCs is dependent on NF-κB activation, measured by upregulation of 
molecules such as MHC and CD86 and TNF-α release (156). Therefore, it is likely 
that YopP inhibits maturation of DCs via inhibition of NF-κB. 
 
In summary, these results indicate that YopP is the most potent pathogenicity factor 
of Y. enterocolitica that prevents DC mediated activation of CD4+ T cells by induction 
of apoptosis, inhibition of DC maturation, and cytokine production. To examine 
whether additional functions of DCs like antigen uptake and processing are affected 
by Y. enterocolitica, T cell proliferation assays with Ova peptide as antigen were 
performed. The Ova peptide can bind directly to the MHC II molecules on the cell 
surface without uptake and processing. Incubation of DCs with Ova peptide after 
infection with wild type Y. enterocolitica did not lead to a reduced T cell proliferation 
compared to uninfected DCs. This result indicates that Y. enterocolitica affects 
somehow antigen uptake and/or antigen processing capacity of DCs. On the other 
hand it demonstrates that although DCs undergo apoptosis and are compromised in 
maturation and secretion of proinflammatory cytokines, they are able to stimulate 
CD4+ T cells efficiently. Therefore, it is more likely that antigen uptake and/or 
antigen processing play the major roles in preventing T cell activation by DCs. 
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4.4 Y. enterocolitica inhibits antigen uptake and processing 
in DCs 
Endocytosis is essential for the presentation of antigens by major histocompatiblity 
complex (MHC) class II molecules. In general, the endocytic capacity of DCs is high 
in the immature stage and down-regulated during maturation (69,200,220). DCs can 
capture soluble antigen mainly via two distinct mechanisms.  
First, the non-specific mechanism of antigen uptake in DCs is macropinocytosis 
(172). Macropinocytosis is a form of high-volume, non-specific endocytosis that 
involves extension of membrane ruffles. Macropinocytosis is highly dependent on 
actin polymerisation (3) and it was shown that Rac-dependent recruitment of PAK1 
kinase and its activation is both necessary and sufficient for macropinocytosis 
(56,57). Macropinocytosis in DCs requires Rac (69,220), and in cells derived from the 
bone marrow it also requires Cdc42 (69). Mellman and co-workers (69) have shown 
that Cdc42 is a cellular key regulator of macropinocytic function in these cells: during 
maturation DCs selectively downregulate Cdc42 activity, but transfection of a 
constitutively active Cdc42 mutant is sufficient to reactivate macropinocytosis. 
However, macropinocytosis in spleen-derived cells appears to be completely 
independent of Cdc42 (220), suggesting that the role of Cdc42 in antigen uptake 
depends on the type of the DCs. 
Second, the clathrin-mediated endocytosis previously referred to as receptor-
mediated endocytosis (43) comprising endocytosis of receptors like low-density-
lipoprotein receptor (LDLR), transferrin receptor (TfR), macrophage mannose 
receptor (MMR), Fc receptors, and members of the C-type lectin family 
(59,152,172,218). These receptors localize to coated pits, which highly increase 
antigen uptake via clathrin-coated vesicles (CCV). In the formation of these CCVs 
several accessory proteins including amphiphysin, dynamin, AP2, and episin are 
involved. It was shown that actin-disrupting agents had only partial or no effect on 
the formation of CCVs (65). Contrary findings from Merrifield et al. revealed that 
actin assembly is spatially and temporally coordinated with the recruitment of 
dynamin to the necks of coated pits, and with the release of CCVs into the cytosol 
(127). These findings suggest that the actin cytoskeleton is not absolutely required 
for clathrin-mediated endocytosis, but instead appears to contribute to the 
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organization and efficiency of this process. Similarly, while Rho GTPases do not have 
an obligate function in clathrin-mediated endocytosis, several studies suggest that 
these signalling proteins act to regulate the efficiency of internalisation. For example, 
Schmid and co-workers showed that constitutively active mutants of either Rac or 
RhoA block internalisation of the transferrin receptor (103). However, expression of 
dominant-negative mutants of these signalling proteins had no effect on receptor 
uptake in intact cells, suggesting that the observed effects of constitutively active 
Rac and RhoA may be an indirect consequence of locking these proteins in the active 
form. In addition, studies with dominant-negative mutants demonstrated that Cdc42 
is not generally required for clathrin-mediated endocytosis (102). While clathrin-
mediated endocytosis acts constitutively in both immature and mature DCs, 
macropinocytosis is down-regulated in mature DCs. 
 
In a first approach antigen uptake was analysed by flow cytometry and fluororeader 
using Ova-FITC as antigen because T cell proliferation assays were performed with 
Ova protein. It is known that Ova is taken up by macropinocytosis (65%) as well as 
clathrin-mediated endocytosis (35%) into a fetal skin-derived dendritic cell line 
representing an immature stage (116). The results observed in this study 
demonstrate that Y. enterocolitica pYV+, but not the YopP-deficient mutant strain 
(pYV+∆yopP), inhibits Ova-FITC uptake by 45%, suggesting that YopP is responsible 
for this decreased antigen uptake in DCs. Consistently, infection of DCs with mutant 
strains deficient for YopE, YopH, and YopT resulted in reduced Ova-FITC uptake 
comparable with the wild type Y. enterocolitica strain (data not shown). 
Interestingly, YopE, YopT, and YopH inhibit actin polymerisation by interacting with 
Rho GTPases or focal adhesion kinases. Therefore, one would expect that if Ova 
uptake is mainly mediated by macropinocytosis the knock out of YopE, YopT, and 
YopH should result in increased uptake of Ova-FITC. It is, however, possible that 
knock out of one Yop can be overcome by the two others, leading to the same 
inhibition of Ova uptake observed with the wild type Yersinia. A second possibility 
would be that Ova uptake in mouse bone marrow derived DCs is mediated 
predominantly via clathrin-mediated endocytosis.  
YopP is known to inhibit the NF-κB and the MAPK pathways (140). Using inhibitors of 
both pathways we could show that inhibition of the MAPK pathway led to a reduction 
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of Ova uptake comparable to that observed with DCs infected with wild type Yersinia. 
In contrast to this, several inhibitors of the NF-κB signalling pathway did not 
influence Ova uptake in DCs (data not shown). Therefore it is likely that YopP inhibits 
Ova uptake via the inhibition of MAPKs. To confirm this hypothesis the inhibitory 
effect of YopP on MAPKs was mimicked by infecting DCs with the YopP-deficient 
mutant strain and subsequently adding MAPK inhibitors. The results demonstrate 
that the addition of MAPK inhibitors to DCs infected with Y. enterocolitica pYV+∆yopP 
leads to a reduction of antigen uptake; thus, the inhibitors “complemented” for the 
YopP deficiency.  
To point out a direct link between the involvement of MAPKs in endocytosis, 
transfection experiments in DCs were performed to over-express dominant negative 
and wild type (controls) constructs for JNK2 and p38 (99). To confirm the 
functionality of the constructs in transfected DCs western blot analyses were 
performed using antibodies to phosphorylated and non-phosphorylated MAPKs. 
Western blot analyses of p38 expression demonstrated an over-expression of p38 in 
DCs transfected with both, the dominant negative and wild type constructs compared 
to the mock control. Indeed, phosphorylation of p38 was high in DCs transfected 
with the wild type control for p38, but not with the dominant negative construct 
(data not shown). These data demonstrate the successful transfection and the 
functionality of the dominant negative construct for p38. Comparable results were 
obtained with the constructs for JNK2 except for the fact that the phosphorylation of 
JNK was not inhibited with the dominant negative construct, which can be explained 
by the fact that the phosphorylation-binding site is conserved in this dominant 
negative mutant for JNK (M. Kracht, personal communication). Therefore, the p-JNK 
antibody is able to bind to the over expressed protein. The dominant negative 
mutant inactivates the kinase by a mutation in their ATP binding site.  
Preliminary results from these studies revealed no differences in Ova uptake between 
DCs transfected with the dominant negative and the wild type constructs for p38, 
JNK, or a mixture of the two constructs. It is likely that despite transfection 
endogenous MAPKs get still phosphorylated. Alternatively the effect of JNK may not 
depend on the enzymatic activity of the protein, but depend on protein-protein 
interactions, that might not be altered by mutation of JNK (M. Kracht, personal 
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communication). To overcome this problem siRNA transfections are necessary to 
prove that MAPKs are involved in antigen uptake.  
 
As DCs may take up Ova by both macropinocytosis and clathrin-mediated 
endocytosis we addressed which of these pathways is involved in our system by 
using inhibitors of each pathway. Competition of mannan with Ova-FITC reduced 
Ova uptake up to15 % indicating a minor role for the MMR in Ova uptake. In 
contrast, Ova uptake was highly actin dependent, as incubation of DCs with CyD, 
which blocks actin polymerisation, reduced Ova uptake up to 55%. These results are 
in agreement with the findings that macropinocytosis as well as clathrin-mediated 
endocytosis are actin dependent, the latter to a lesser degree (3,127). As co-
incubation of DCs with Yersinia wild type strain and CyD synergistically reduced Ova 
uptake one can conclude that inhibition of Ova uptake by Yersinia is partially 
independent of actin assembly. As macropinocytosis is highly dependent on Rho 
GTPases toxin B from C. difficile was added, which inhibits RhoA, Rac1, and Cdc42 
prior to addition of Ova. We observed no significant reduction of Ova uptake by toxin 
B from C. difficile, indicating a minor role for Rho GTPases in Ova uptake. These data 
are in contrast to recent findings from Mellman and co-workers, demonstrating that 
toxin B from C. difficile inhibits uptake of Ova up to 80% (69). In the study from 
Mellman and co-workers DCs were generated from C3H/HeN mice according to the 
protocol of Inaba et al. (88) and used for experiments at day 6 of culture. In 
contrast, the DCs used in this study were from BALB/c mice according to the protocol 
of Lutz et al. (115) and the cells were used for the experiments at day 8 of culture. 
Therefore, we generated DCs according to both protocols and analysed their 
maturation stage, as well as Ova uptake with or without addition of TcdB (data not 
shown). Preliminary data show that the role of Rho GTPases in Ova-FITC uptake by 
DCs depends on mouse strains.  
The experiments performed with the inhibitors of proteins involved in endocytosis did 
not clarify exactly to what degree Ova is taken up by macropinocytosis or clathrin-
mediated endocytosis. This is due to the fact that actin is involved in both 
macropinocytosis as well as clathrin-mediated endocytosis.  
Therefore, Tf and LY, which are internalised by molecular defined pathways, were 
used to further address this issue. Tf was used as a marker for clathrin-mediated 
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endocytosis, because it is specifically internalised via binding to the Tf-receptor 
(116). Clathrin-mediated endocytosis of Tf-TfR complex is a constitutive process. The 
complex is taken up into early endosomes, where Tf is released from the receptor, 
which is rapidly recycled to the cell surface (42). Both Y. enterocolitica wild type and 
MAPK inhibitors reduced uptake of Tf in DCs whereas the YopP-deficient Yersinia 
mutant strain did not. These results correspond to those obtained with Ova and 
demonstrate that YopP of Y. enterocolitica reduces clathrin-mediated endocytosis 
most likely by inhibiting MAPKs. 
Interestingly, macropinocytosis of LY in DCs infected with Y. enterocolitica was also 
inhibited up to 70%, indicating that Y. enterocolitica is also able to block 
macropinocytosis. However, uptake of LY by DCs infected with the YopP-deficient 
mutant strain was reduced comparable to the Yersinia wild type strain. These data 
demonstrate that YopP does not play a role in the inhibition of macropinocytosis in 
DCs infected with Y. enterocolitica. In agreement with these findings, incubation of 
DCs with MAPK inhibitors did not significantly reduce uptake of LY. In contrast, TcdB 
and CyD dramatically reduced LY uptake in DCs. Based on these results it is more 
likely that YopE, YopH, or YopT are involved in the inhibition of macropinocytosis in 
DCs by Y. enterocolitica. To find out which of these Yops affects macropinocytosis in 
DCs further experiments using mutant strains for YopE, YopH, and YopT are needed. 
Taken together, the data observed with Tf and LY demonstrate that YopP of Y. 
enterocolitica inhibits clathrin-mediated endocytosis of Tf, but not macropinocytosis 
of LY. As inhibition of Rho GTPases reduced uptake of LY in DCs, but not uptake of 
Ova, one can conclude that Ova is endocytosed by DCs from BALB/c mice according 
to the protocol of Lutz et al. mainly via clathrin-mediated endocytosis.  
 
A well-documented characteristic of DC maturation is the progressive down-
regulation of endocytosis (69,172,220). Recently Watts and co-workers 
demonstrated that TLR ligands first acutely stimulate antigen macropinocytosis 
(221). In this study they stimulated DCs with low doses of LPS for 30 min and then 
pulsed with FITC-dextran for 10 min and analysed for antigen uptake. They observed 
several times more accumulation of FITC-dextran in DCs with LPS stimulation 
compared to untreated DCs. However, this enhancement was transient, peaking after 
30 min of LPS stimulation in bone marrow DCs. This transient upregulation of 
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endocytosis was dependent on actin assembly and p38 and ERK activation. To assess 
whether in the system used in this study the observed inhibition of Ova uptake in 
DCs treated with Y. enterocolitica and/or MAPK inhibitors is due to the inhibition of 
LPS stimulated MAPKs, DCs from TLR2-/-xTLR4-/- mice were infected with Yersinia 
wild type and the YopP-deficient mutant strain, as well as treated with MAPK 
inhibitors and analysed for Ova uptake. The results revealed that Ova uptake by DCs 
infected with Y. enterocolitica or incubated with inhibitors of MAPKs is independent of 
the TLR2 and TLR4 signalling pathway, indicating a differential role for MAPKs than 
that described by West et al. (221). Similar results were also obtained for DCs from 
MyD88-/- and TRIF-/- mice.  
 
Little is known about the role of MAPKs in endocytosis. Recent findings from Shang 
et al. revealed an important role for MAPKs in the regulation of amphiphysin 1 during 
clathrin-mediated endocytosis of the NGF receptor (187). Amphiphysin 1, which can 
simultaneously bind to dynamin 1 and the clathrin adaptor AP-2, is essential for 
dynamin recruitment during clathrin-mediated endocytosis (Fig. 4.1). The authors 
found that amphiphysin 1 is phophorylated by MAPKs in response to NGF stimulation 
of PC12 cells. MAPK-dependent phosphorylation of amphiphysin 1 negatively 
regulated the association of amphiphysin1 with AP-2 adaptor. Therefore, they 
speculate that MAPKs control NGF receptor-mediated endocytosis by terminating the 
interaction between amphiphysin1 and AP-2. In contrast to our findings, the results 
from Shang et al. demonstrate that activation of MAPKs inhibits clathrin-mediated 
endocytosis. 
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Fig. 4.1: Model for the role of MAPKs in phosphorylation of amphiphysin (from Shang 
et al. (187)) 
NGF stimulates the NGF receptor tyrosine kinase TrkA and in turn transmits activation 
signals through the Ras-Raf-MAPKKMAPK pathway to the nucleus, leading to neurite 
outgrowth in PC12 cells. Concomitantly, MAPKs phosphorylate amphiphysin1, and 
phosphorylated amphiphysin1 dissociates from the AP-2 adaptor, resulting in the 
recycling of amphiphysin1-dynamin (Dyn) complexes during NGF receptor-mediated 
endocytosis. 
 
A third study reported that the MAPK p38 regulates endocytic trafficking via the 
GDI:Rab5 complex (36). Rab5 is one of the key regulators of early endocytic traffic 
and coordinates different trafficking events, like homotypic early endosome fusion 
(70), internalisation (34), clathrin-coated vesicle formation (124), and motility of 
early endosomes on microtubules (136). Rab5 cycles between GTP- and GDP-bound 
states as well as between membrane and cytosol. Cavalli et al. provide evidence that 
the protein kinase p38 MAPK regulates GDI activity in the cytosolic cycle of the small 
GTPase Rab5 (36). They also found that activation of p38 MAPK modulates endocytic 
rates, and this modulation was reduced in p38α−/− fibroblasts. These data indicate 
that membrane traffic can be controlled by external stimuli, emphasizing the possible 
role of trafficking regulation in infection, aging, and a number of degenerative 
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diseases. Therefore, we speculate that inhibition of endocytosis by YopP via MAPKs 
may lead to a reduced formation of GDI:Rab5 complexes, which needs to be 
investigated in future studies. 
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Ovalbumin
Macropinocytosis
Actin
Macropinosome
AP2
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Clathrin-mediated endocytosis
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YopPMAPKs
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YopH?
 
Clathrin YERSINIA
Fig. 4.2: Model for the modulation of endocytosis by Y. enterocolitica 
Y. enterocolitica inhibits clathrin-mediated endocytosis as well as macropinocytosis. 
Inhibition of clathrin-mediated endocytosis by Yersinia is mediated by YopP most likely via 
the inhibition of MAPKs. Inhibition of macropinocytosis is independent of YopP. EE early 
endosome; LE late endosome 
 
Taken together, the studies reported in this thesis demonstrate that YopP of Y. 
enterocolitica is able to inhibit antigen uptake via clathrin-mediated endocytosis most 
likely by inhibiting MAPK signalling pathways (Fig. 4.2). Macropinocytosis in DCs is 
also inhibited by Yersinia, but until now it is not clear which effector protein is 
responsible for this effect. Therefore, further studies including siRNA and co-
immunoprecipitation experiments are needed to build a direct link between YopP and 
MAPKs and to elucidate, which of the proteins that are essential in endocytosis are 
targeted by MAPKs in DCs by performing, respectively. 
 
In addition, we found that Y. enterocolitica inhibits the activation of proteins 
essential for antigen degradation and maturation of newly synthesized MHC class II 
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molecules (85). The results reveal that the inhibition is not selective for one 
cathepsin and the amount of total cathepsins is not affected by Y. enterocolitica. The 
inhibition of cathepsins is dependent on plasmid-encoded factors, but not on YopP. 
Experiments using mutant strains deficient for single Yops did not clarify which 
effector molecule of Y. enterocolitica prevent the activation of the cathepsins. 
Therefore, it is possible that two or more Yops synergistically inhibit the activation of 
cathepsins. These results indicate that Y. enterocolitica may affect antigen 
processing in DCs. Whether the inhibition of cathepsins by Y. enterocolitica in DCs 
leads to inhibition of antigen degradation and MHC class II maturation needs to be 
analysed in further experiments. 
Molinari et al. demonstrated that Helicobacter pylori inhibits antigen processing in a B 
cell line (131). By using T cell clones with different specificity, they found that the 
toxin VacA of H. pylori interferes with the generation of T cell epitopes loaded on 
newly synthesized molecules (the invariant chain [Ii]-dependent pathway of antigen 
presentation), leaving unaffected generation and presentation of epitopes by class II 
molecules that recycle through early endosomal compartments (Ii-independent 
pathway). 
 
In conclusion, this study demonstrates that plasmid-encoded virulence factors of Y. 
enterocolitica impair the T cell activation capacity of mouse DCs by various means. 
YopP has found to be the most prominent effector protein of Y. enterocolitica 
affecting immunological functions of DCs (Fig. 4.3). YopP induces cell death in DCs 
by a mechanism that has features of both apoptosis and necrosis. The mechanism as 
well as the target proteins of YopP involved in the induction of cell death still have to 
be investigated. By its ability to inhibit NF-κB activation, YopP blocks the 
upregulation of MHC class II and costimulatory molecules, which requires NF-κB 
activation (156). YopP of Y. enterocolitica inhibits the production of proinflammatory 
cytokines and cytokines required for T cell activation and differentiation into effector 
T cells, which is dependent on activation of NF-κB and MAPK pathways (156). 
Furthermore, YopP reduces most likely via inhibition of MAPKs, antigen uptake by 
clathrin-mediated endocytosis, whereas macropinocytosis is reduced by other yet not 
defined effector proteins. It would be interesting to analyse the role of MAPKs in 
clathrin-mediated endocytosis and their link to YopP. In addition, inhibited activation 
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of cathepsins in DCs infected with different mutant strains of Y. enterocolitica 
provided evidence that antigen processing in DCs is also impaired by Y.
enterocolitica. However, it is not clear whether this effect is also mediated by YopP 
or by other effector proteins. Furthermore, it has to be investigated which part of the 
antigen processing pathway may be affected by the inhibited activation of cathepsins 
caused by Y. enterocolitica in DCs. However, as these observations have been 
obtained by in vitro experiments, therefore further studies are required in order to 
investigate whether the aforementioned functions of DCs affected by Y  enterocolitica 
might subvert the adaptive immune defence mechanisms of the host in vivo. 
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Fig. 4.3: Model for the modulation of DCs by Y. enterocolitica; adapted from Cornelis et 
al. (46) 
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5 Summary 
Yersinia enterocolitica is able to evade components of the innate immune system like 
phagocytosis by PMNs and lysis by complement by proteins encoded by the virulence 
plasmid pYV like the outer membrane protein YadA and secreted anti-host effector 
proteins (Yops). The production of the cytokines TNF-α, IL-12, IL-18, and IFN-γ as 
well as the activation of CD4 T cells and macrophages are essential to control 
Yersinia infection. Whether Y. enterocolitica also affects adaptive immune responses 
was not yet known. The aim of this work was to investigate whether and how Y. 
enterocolitica affects the immunogenic properties of mouse DCs in vitro. The results 
demonstrate that plasmid-encoded pathogenicity factors of Y. enterocolitica 
completely abolish the ability of DCs to activated CD4+ T cells. Taking advantage of 
Y. enterocolitica mutant strains deficient for various Yops, it was demonstrated that 
particularly the secreted protein YopP accomplished the immune evasion of DCs by 
various effects: (i) Y. enterocolitica YopP induces cell death in mouse DCs. (ii) YopP 
inhibits maturation of DCs as demonstrated by reduced upregulation of MHC class II 
and costimulatory molecules and inhibition of cytokine release. (iii) Y. enterocolitica 
reduces antigen uptake in DCs by two different mechanisms: YopP inhibits clathrin-
mediated endocytosis, most likely via the inhibition of MAPK; in addition, other not 
yet defined effector proteins of Y. enterocolitica reduce macropinocytosis. (iv) Y. 
enterocolitica also inhibits the activation of cathepsins, molecules involved in antigen 
degradation and MHC class II maturation, suggesting that effector proteins of Y. 
enterocolitica affect antigen processing in DCs. These results demonstrate that YopP 
is a multifunctional effector protein, which disturbs several cell functions required to 
mount adaptive immune responses. Moreover, the results show that analyses of 
molecular basis of microbial virulence factors reveal interesting insights into host cell 
functions and immune responses. Further studies will have to reveal the target 
proteins and mechanisms involved in YopP mediated cell death and inhibition of 
clathrin-mediated endocytosis. As these observations have been obtained by in vitro 
experiments, further studies will also have to elucidate whether by targeting the 
aforementioned functions of DCs Y. enterocolitica might actually contribute to 
subvert the adaptive immune defence mechanisms of the host in vivo. 
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6 Abbreviations
Ail attachment invasion locus  
Amp
R ampicilin resistant  
APC antigen presenting cell 
APS ammoniumpersulfat  
BCA bicinchoninic acid  
BSA bovine serum albumin  
C carbon  
Ca Calcium  
Cat cathepsin 
CCR chemokine receptor 
CD cluster of differentiation  
CFSE 5-(6)-carboxyfluoresceine diacetate N-  
 succinimidylester (CFDA,SE)  
Cl Chlor  
CLIP class II-associated invariant chain peptide 
Cm
R  Chloramphenicol-Resistenz  
CME  clathrin-mediated endocytosis 
CR complement receptor 
CTL cytotoxic T lymphocyte  
CyD cytochalasin D 
DC dendritic cell 
DMSO Dimethylsulfoxid  
DNA desoxyribonucleic acid  
dNTP Desoxyribonucleosidtriphosphate  
dTTP desoxy-thymidintriphosphate  
ECL enhanced chemoluminescence  
EDTA Ethylenediaminetetraacetic acid  
ELISA Enzyme-linked immunosorbent assay  
ER Endoplasmatic Reticulum  
et al. and others  
FACS flourescence activated cell sorter  
Fig. figure 
FITC fluoresceine isothiocyanate  
FCS fetal calf serum 
G guanine 
g Earth’s acceleration 
GALT gut associated lymphoid tissue  
GM-CSF granulocyte-monocyte colony stimulating 
factor  
H hydrogen  
h  hour  
HBSS Hank's balanced salt solution  
HK  heat-killed  
HLA  human leucocyte antigen  
HPI  high pathogenicity island  
HRP  horse-radish peroxidase 
IFN  interferon  
Ig  immunglobulin  
Ii  invariant chain 
IL  interleukin  
Inv  invasin 
i.v. intravenously 
kDa  kilo Dalton  
LB  Luria Bertani  
Lcr  low Calcium response  
LPS  lipopolysaccharid  
LY  lucifer yellow 
MCP-1  macrophage chemoattractant protein  
M  molar  
MALT  mucosa associated lymphoid tissue  
MAPK mitogen activated protein kinase 
Mg magnesium  
MHC  major histocompatibility complex  
min  minute  
MOI  multiplicity of infection  
Myf  mucoid Yersinia factor  
M cell  membraneous cell  
N  nitrogen 
Na  sodium  
Nal
R  
nalidixin resistant  
NF  nuclear factor  
NK  natural killer  
O  oxygen 
OD  optical density  
Ova  Ovalbumin  
P Phosphor  
p  probability  
PAGE  polyacrylamide gel electrophoresis  
PAMP  pathogen-associated molecular pattern 
PBS  phosphate buffered saline  
PE  Phycoerythrin  
PFA  paraformaldehyde  
PI  propidium iodide 
PMN  polymorphonuclear neutrophils 
PMSF  phenyl-methyl-sulfonylfluoride  
pYV  plasmid Yersinia Virulence  
PVDF  polyvinylidenfluoride  
Rho  Ras homologous  
RNA  ribonucleic acid 
rpm  rounds per minute 
RPMI Roswell Park Memorial Institute  
SD standard deviation 
SDS  sodium dodecyl sulfate  
sodA  superoxid dismutase A  
Spec
R  
spectinomycin resistant  
ssp.  species 
Syc  specific Yop chaperone  
T  thymidine  
Tab.  table 
TAP  transporter associated with antigen 
processing  
TcdB  Clostridium difficile toxin B 
TCR  T cell receptor  
TEMED  N,N,N',N'-tetramethyl-ethylenediamine  
Tf  transferrin 
TH1  T helper cell type 1 
TH2  T helper cell type 2 
TLR  Toll like receptor 
Tris  tris(hydroxymethyl)aminomethan 
TTSS  type three secretion system 
IKK  inducible IκB-kinase  
TNF  Tumor necrosis factor  
U  unit  
YadA  Yersinia adhesin A 
Yop  Yersinia outer protein 
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